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Identification of endophenotypes (I. I. Gottesman & Gould, 2003; I. I. Gottesman & Shields, 1972) 
that correlate with familial liability to schizophrenia and are maximally sensitive to a homogeneous 
subset of risk genes is an important strategy for detecting genes that affect schizophrenia risk. 
Symptoms of schizotypy may correlate with familial liability to schizophrenia; however, there are 
critical limitations of the current literature concerning this association. The present study examined 
the genetic architecture and genetic association between schizotypy and genetic liability to 
schizophrenia among multigenerational, multiplex schizophrenia families. Genetic schizotypy 
factors were identified that significantly correlated with genetic liability to schizophrenia, although 
some relations were unexpected in direction. These genetic factors did not correlate with genetic 
liability to major depressive disorder or substance dependence. Results suggest that genetic 
schizotypy factors may have the potential to be particularly useful endophenotypes in genetic 
linkage analyses of schizophrenia. 
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1.0  INTRODUCTION. 
Family, twin, and adoption studies suggest that schizophrenia is a highly heritable disorder 
[estimated at approximately 0.80 (Cardno et al., 1999)]. However, despite numerous attempts to 
identify specific genes contributing substantially to the risk for schizophrenia, the only promising 
candidates are those that contribute a small degree of risk. This implies that the diagnosis of 
schizophrenia most likely is associated with numerous genes of small effect rather than any 
single gene variant (O'Donovan, Williams, & Owen, 2003; Pogue-Geile & Gottesman, 2007). 
Consistent with this idea is substantial evidence that genetic liability to schizophrenia is present 
in non-psychotic relatives of schizophrenia patients. One of the most convincing demonstrations 
of this came from Gottesman and Bertelsen’s (1989) follow up of Fischer’s (1971) Danish 
sample of discordant monozygotic (MZ) and dizygotic (DZ) twins and their offspring. The risk 
for schizophrenia in the offspring of unaffected MZ co-twins was substantially higher than that 
in the offspring of unaffected DZ co-twins (17.4% in offspring of MZ co-twins, 2.1% in 
offspring of DZ co-twins), supporting the presence of “unexpressed” genetic liability in non-
schizophrenia relatives that is correlated with degree of genetic relatedness to an affected 
individual and that can be transmitted to offspring. 
Even in the absence of psychosis, genetic liability to schizophrenia may indeed produce 
observable effects in these “unaffected” relatives. For example, research with non-psychotic 
adult relatives has revealed “sub-clinical” neuropsychological deficits and behavioral patterns 
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that are similar to, but less severe than those of schizophrenia patients, including reduced 
performance on tasks of executive functioning, verbal and visual memory, auditory attention, 
visual scanning and sequencing, and social perception (e.g., Faraone, Seidman et al., 1995; 
Faraone et al., 2000; Thompson, Watson, Steinhauer, Goldstein, & Pogue-Geile, 2005; Toomey, 
Seidman, Lyons, Faraone, & Tsuang, 1999). Similar observations have been noted in children of 
schizophrenia patients, including poor performance on measures of inhibition, working memory, 
and verbal abilities, as well as problematic social behavior (e.g., solitary play, passivity, social 
anxiety, disruptiveness, aggression), poor peer relationships, and reduced social competence, 
compared to age-matched, non-high-risk peers (e.g., Asarnow, 1988; Davalos, Compagnon, 
Heinlein, & Ross, 2004; Davies, Russell, Jones, & Murray, 1998; Niemi, Suvisaari, Haukka, & 
Lonnqvist, 2005; Olin & Mednick, 1996; Tarbox & Pogue-Geile, 2008). 
The presence of “sub-clinical” deficits among non-schizophrenia relatives suggests that 
these phenotypes are more sensitive to genetic liability to schizophrenia than is the diagnosis of 
schizophrenia itself, and perhaps could be used to search more powerfully for individual genes 
contributing to schizophrenia risk. Accordingly, an important strategy is the identification of 
such supplementary phenotypes [i.e. “endophenotypes” (I. I. Gottesman & Gould, 2003; I. I. 
Gottesman & Shields, 1972)] that correlate with the familial liability to schizophrenia in the 
absence of psychosis. To be most useful for understanding schizophrenia, these phenotypes     
should also be sensitive to schizophrenia liability in particular, rather than simply be an 
indication of liability to psychopathology in general (Faraone, Kremen et al., 1995).  
However, even if a putative phenotype is elevated in relatives, its sensitivity to specific 
risk genes would be compromised to the extent that it is itself genetically heterogeneous. Thus, 
to the degree that a putative endophenotype approximates genetic homogeneity and correlates 
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with genetic liability to schizophrenia, the more likely it is to enhance sensitivity to specific risk 
genes. 
1.1 SCHIZOTYPAL PERSONALITY DISORDER AND LIABILITY TO 
SCHIZOPHRENIA. 
1.1.1 Historical Roots. 
The belief that “sub-clinical” cognitive and interpersonal deficits of non-psychotic relatives are 
important in the conceptualization of schizophrenia liability is not new. For example, 
observations of abnormal interpersonal functioning in the family members of schizophrenia 
patients (e.g., social isolation/withdrawal, suspiciousness, irritability, eccentricity) can be found 
among the earliest descriptions of schizophrenia (Dementia Praecox) by Kraeplin (1919) and 
Bleuler (1911) (among others), both of whom hypothesized the existence of a “latent 
schizophrenia” syndrome among relatives (I. I. Gottesman, 1991; Kendler, 1985). In the decades 
following the early writings of Kraeplin and Bleuler, similar observations have been recorded 
and integrated into influential theories of schizophrenia liability. 
Contemporary models of schizophrenia liability can be traced back to the work of Sandor 
Rado and Paul Meehl, who built upon the observations of Kraeplin and Bleuler and extended the 
idea of “latent schizophrenia”. Rado (1953) introduced the term “schizotype” (schizophrenic 
genotype) to describe non-psychotic individuals who displayed schizophrenic traits such as 
anhedonia, reduced affect, and interpersonal impairments, and thus seemed to share a common 
genetic liability with schizophrenia. Meehl (1962) proposed that the sub-clinical, “schizophrenia-
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like” characteristics observed in relatives were manifestations of the interaction between an 
inherited “neural integrative defect” predisposing to schizophrenia, which he termed 
“schizotaxia”, and the environmental experiences of that individual. According to Meehl, the 
typical outcome of this interaction was a specific personality organization characterized by traits 
previously described by Kraeplin (1919) and Bleuler (1911): interpersonal aversiveness, 
anhedonia, ambivalence, and cognitive slippage. After Rado (1965), Meehl referred to this 
syndrome as “schizotypy” and to these individuals as “schizotypes”. He theorized that although a 
subset of schizotaxic individuals would develop schizophrenia, schizotypy would be the more 
typical manifestation of inherited liability to schizophrenia. Meehl’s model became the 
foundation for a number of important and productive contemporary research strategies aimed at 
investigating the nature of liability to schizophrenia (e.g., Faraone, Green, Seidman, & Tsuang, 
2001; I. I. Gottesman & Gould, 2003; Lenzenweger, 2006). 
1.1.2 Development of Diagnostic Criteria. 
The first significant effort to develop diagnostic criteria for Bleuler’s concept of “latent 
schizophrenia”, and to clarify the role of genetic factors in this syndrome, was undertaken by 
Kety and colleagues in the context of the Copenhagen Adoption Study (Kety, Rosenthal, 
Wender, & Schulsinger, 1968). Kety et al. (1968; Kety et al., 1994) confirmed the presence of 
schizophrenia-like traits among the biological relatives of adoptees with schizophrenia, and 
demonstrated that the prevalence of these traits among biological relatives of adoptees with 
schizophrenia was significantly greater than in the biological relatives of controls. These findings 
provide strong support that this syndrome is associated with genetic liability to schizophrenia.  
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Kety grouped these schizophrenia-like traits into five categories (interpersonal deficits, 
atypical speech, cognitive/perceptual distortions, affective deficiencies, and neurotic symptoms) 
and proposed the diagnosis “borderline schizophrenia” to describe this syndrome. The criteria for 
this proposed diagnosis were subsequently modified by Spitzer et al. (1979) and incorporated 
into the third edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-III; 
American Psychiatric Association, 1980) as Schizotypal Personality Disorder (for reviews see 
Kendler, 1985; Siever & Gunderson, 1983).  
In the current edition of the DSM (DSM-IV-TR), schizotypal personality disorder (SPD) 
is described as a “…pervasive pattern of social and interpersonal deficits marked by acute 
discomfort with, and reduced capacity for close relationships as well as by cognitive or 
perceptual distortions and eccentricities of behavior...” (American Psychiatric Association, 
2000). The full diagnostic criteria are provided in Table 1. As can be seen, deficits in social and 
interpersonal functioning are core features of this diagnosis.   
1.1.3 Current Status. 
The observations of Kety and colleagues continue to find support. Recent data from family, twin, 
and adoption studies suggests that SPD is highly heritable (estimated at .61; Torgersen et al., 
2000) and among non-psychotic adult relatives of schizophrenia patients, the incidence of SPD is 
estimated to be between 4.2% and 14.6% (Tsuang, Stone, & Faraone, 1999) compared to 2-3% 
among the general population (Raine, 2006) [odds ratio (OR) estimated at 5.0 (Kendler & 
Gardner, 1997)]. Furthermore, an analysis of genome-wide linkage data by Fanous et al. (2007) 
provides support for genetic correlation between schizotypy and schizophrenia. 
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Specificity to schizophrenia liability also has been examined. These results indicate that 
the prevalence of SPD is significantly greater in non-psychotic relatives of schizophrenia patients 
(6.9%) than in relatives of patients with schizoaffective disorder (2.8%) , affective psychosis 
(2.5%), or non-psychotic affective disorders (2.3%) (K.S. Kendler et al., 1993; Pogue-Geile, 
2003), although there are some contradictory findings (e.g., Erlenmeyer-Kimling et al., 1995; 
Kety et al., 1994). It has been further estimated that a considerable number of relatives not 
meeting criteria for the diagnosis of SPD may nevertheless display subclinical schizotypal traits 
(Tsuang et al., 1999). 
Although SPD may also occur in the general population, the etiology of this diagnosis in 
non-relatives is likely to be heterogeneous (MacDonald, Pogue-Geile, Debski, & Manuck, 2001). 
Furthermore, the nature of the deficits associated with SPD in non-relatives is controversial. 
Some researchers have argued that there may be important differences in symptom presentation 
between relatives of schizophrenia patients diagnosed with SPD and general population cases 
(for reviews, see Kendler, 1985; Tsuang, Stone, Tarbox, & Faraone, 2002). For example, it has 
been suggested that in relatives, SPD may be more often characterized by social and affective 
deficits, whereas SPD diagnosed in the general population may be characterized by perceptual 
aberrations and odd beliefs (Thaker, Moran, Adami, & Cassady, 1993; Torgersen, 1985; 
Torgersen et al., 2002). However, this distinction is not consistently observed (e.g., Condray & 
Steinhauer, 1992). Thus at present, the true extent and source of these observed differences is not 
clear, but nevertheless suggests limitations to the study of SPD in the general population. 
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1.2 REVIEW OF SPD SYMPTOMS IN RELATIVES OF SCHIZOPHRENIA 
PROBANDS. 
An important step for further investigating the putative association between schizotypal 
impairments and genetic risk for schizophrenia is to assess the degree to which SPD is elevated 
among non-psychotic relatives of schizophrenia patients. Although it is interesting to know if the 
SPD diagnosis itself is associated with schizophrenia liability, the degree to which individual 
symptoms of SPD are correlated with genetic liability to schizophrenia may be particularly 
informative. If schizotypy is associated with schizophrenia liability, then we would expect non-
psychotic relatives of schizophrenia patients to have more severe symptoms of SPD compared to 
healthy controls, and perhaps greater severity of SPD symptoms than relatives of individuals 
with other psychiatric disorders. To examine the current evidence for elevation of schizotypy in 
non-psychotic relatives of schizophrenia patients, we next review studies that examined SPD 
symptoms among relatives of schizophrenia patients in contrast to non-psychiatric controls 
and/or relatives of other psychiatric groups.  
1.2.1 Methodological Considerations. 
Before reviewing this set of studies, there are a few key methodological issues relevant to the 
task of evaluating and synthesizing these data that should be discussed. These include use of 
first-degree index relatives, control sample composition and matching to index relatives, 
measurement of schizotypal traits, defining the factor structure of schizotypy, symptom-level 
comparisons, and variability in reported statistics. The data examined in this review are 
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presented in Tables 2 – 4, and include information relevant to the methodological points 
highlighted here. 
Foremost, in familial liability schizophrenia studies, first-degree relatives are primarily 
recruited for the index relative sample. Although understandable, exclusive use of first-degree 
relatives raises two primary concerns. First, for several reasons, first-degree relatives tend to be a 
heterogeneous group. For example, first-degree relative samples may include parents, siblings, 
and/or offspring of patients. Although all first-degree relatives, these individuals differ in their 
risk for schizophrenia [relative risk: parents ~ 5%, siblings and offspring ~ 10% (K. S. Kendler et 
al., 1993)], in their experience of living with an individual with schizophrenia, and in prevalence 
of SPD. For example, reports suggest that SPD may be more than twice as prevalent in the 
parents of schizophrenia probands compared to siblings (Roscommon Family Study; K.S. 
Kendler et al., 1993), perhaps an effect of diminished reproductive fitness in schizophrenia 
(Kendler, 1986). If assessed at the same point in time, age differences among parents, siblings, 
and offspring is another potential source of heterogeneity that may affect results. In addition, 
although many studies do exclude relatives with a personal history of psychosis, this is not 
always the case; inclusion of “unscreened” relatives could inflate index/control differences. 
These sources of variation among first-degree relatives can obscure meaningful group 
differences and make comparisons across studies more difficult.  
In addition to heterogeneity, exclusive use of first-degree relatives provides only one 
source of data on non-psychotic individuals with elevated genetic liability to schizophrenia. 
Thus, any observed association with schizophrenia liability is based solely on two data points, 
the first-degree relative sample and the control group, making non-linear genetic effects difficult 
to detect and potentially leading to erroneous conclusions. In contrast, non-first-degree relatives 
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are an underutilized resource that could help clarify differences between relatives and 
comparison samples. At present, the strength of familial correlation of schizotypal traits across 
multiple degrees of relationship to schizophrenia remains virtually untested (although see 
Ritsner, Karas, & Ginath, 1993) 
A second key methodological issue pertains to the characteristics of the comparison 
group(s) and the extent to which this group is matched demographically to the index relatives. 
Control groups typically consist of individual control probands or, less often, relatives of control 
probands. Use of relatives of control probands, rather than the initially screened control 
individuals, is a stronger technique for minimizing confounds with recruitment strategy and 
increasing demographic representativeness. Control groups also vary in terms of how thoroughly 
they are screened for psychiatric illness, ranging from “no diagnosis” (psychiatrically healthy 
individuals whose relatives also are healthy), to “unscreened” (individuals and their relatives 
may or may not have psychiatric diagnoses). Both extremes can be problematic, as a 
“supernormal” control group can inflate index/control differences (Kendler, 1990), and confound 
the effect of relatedness to a schizophrenia proband with relatedness to any psychiatric ill 
individual. However, completely unscreened controls may inadvertently include individuals who 
themselves have a schizophrenia-spectrum diagnosis. To limit such confounds, moderate 
screening combined with careful demographic matching of comparison groups to the index 
relatives is probably best. Alternatively, given their shared family of origin, non-first-degree 
relatives of schizophrenia probands may actually constitute a more appropriate comparison 
group for assessing first-degree relatives than unrelated individuals, avoiding many of the 
problems of ascertaining non-relative controls.  
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Third, the type of instrument used to assess SPD symptoms can affect the outcome and 
interpretation of results. Use of different measures may influence the factor structure of 
schizotypal symptoms and there is evidence that compared to interview-based measures, 
questionnaires may be less sensitive to certain schizotypal traits in relatives, particularly social 
deficit symptoms of schizotypy (Catts, Fox, Ward, & McConaghy, 2000; Kendler, Thacker, & 
Walsh, 1996), and perhaps behavioral eccentricities. Consequently, measurement differences 
may lead to inconsistencies regarding which schizotypal traits appear most salient in relatives, 
and may be misleading regarding the strength of association with familial liability to 
schizophrenia. Given the concerns about questionnaire measures, in our review we tend to 
weight results from interview-based assessments more heavily.  
Fourth, there is an ongoing debate regarding the phenotypic factor structure purported to 
underlie schizotypal traits in relatives. Proposed factor solutions range from two (Siever & 
Gunderson, 1983; Widiger, Frances, Warner, & Bluhm, 1986) to seven (Kendler, McGuire, 
Gruenberg, & Walsh, 1995) and seem to depend a large part on study methodology, including 
sample characteristics and use of questionnaire versus interview measures. Recently, Bergman et 
al. (2000) tested five models using data from interview measures of SPD conducted with adult, 
first-degree relatives of schizophrenia patients and concluded that the best fit was provided by 
the following three-factor model: 1) social-interpersonal symptoms (i.e. “negative schizotypy”), 
including excessive social anxiety, lack of close friends or confidants, constricted affect, and 
suspiciousness; 2) cognitive-perceptual symptoms (i.e. “positive schizotypy”), characterized by 
ideas of reference, odd beliefs/magical thinking, and unusual perceptual experiences; 
suspiciousness also loaded on this factor; and 3) disorganized symptoms of odd speech and odd 
behavior. A variation of this factor structure of SPD was identified in patients with personality 
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disorders in which paranoid symptoms defined the third factor instead of disorganized symptoms 
(A.J. Bergman et al., 1996). Several recent studies, including those using both interview and 
questionnaire measures, also have reported three schizotypy factors (typically identifying 
disorganization as the third factor). Accordingly, the data reviewed below are organized into the 
three dimensions suggested by Bergman et al. (2000): social-interpersonal, cognitive-perceptual, 
and disorganized. For studies that provided alternate factor solutions, we present those data with 
the factor (from the three-factor solution) that best approximates the associated symptoms.  
A fifth methodological issue is that symptom-level comparisons are not consistently 
reported, even when factor comparisons are significant. Although there are similarities among 
symptoms within a single factor, each symptom represents a relatively unique deficit or 
behavior. Thus, examination of individual SPD symptoms among groups can help clarify if 
specific symptoms account for group differences, or if the contribution of multiple deficits is 
most important. When available, we review symptom-level group comparisons along with the 
factor comparisons. 
Lastly, indexes of association, such as odds ratios and effect sizes, are very helpful for 
determining the strength of an association; however, there is substantial variability in which 
indexes are reported. This can hinder comparisons across studies and if a uniform index is 
desired, necessitates conversion of one index into another. There are a number of suggested 
methods for such transformations depending on the available statistics, which although useful, 
raises the concern that transformed indexes may not be entirely equivalent due to variation in the 
original statistics. Furthermore, such transformation calculations are not always feasible given 
the data provided. 
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1.2.2 Review of SPD Symptoms in Relatives versus Non-Relatives.  
With these methodological points in mind, we now review studies that compared adult relatives 
of schizophrenia patients, psychiatrically healthy controls, and/or adult relatives of patients with 
other psychiatric diagnoses on the social-interpersonal, cognitive-perceptual, and disorganization 
dimensions of SPD. These data are presented in Tables 2 - 4. As our focus here is on the relation 
between the symptoms of SPD and familial liability to schizophrenia, we only included studies 
that assessed factors and/or individual symptoms of SPD rather than just the presence of 
diagnosis itself. Whenever possible, we present results for both the factors and the symptoms 
underlying those factors.  
Effect sizes are presented to aid in the comparison of results across studies. When 
possible, all reported indices are converted to Glass’ standardized mean difference statistic ‘d’ 
[relatives mean – control mean / control standard deviation (Smith, Glass, & Miller, 1980)]. As a 
group, relatives of schizophrenia patients are predicted to be more heterogeneous than healthy 
controls, therefore Glass’ ‘d’ is more appropriate than Cohen’s ‘d’, which uses the pooled 
standard deviation of relatives and controls. However, given that effect size transformations 
discussed in the current meta-analysis literature most often utilize Cohen’s ‘d’, in some instances 
it was more feasible to transform reported indices to Cohen’s ‘d’ rather than Glass’ ‘d’ (Cohen, 
1987; Haddock, Rindskopf, & Shadish, 1998; Hasselblad & Hedges, 1995; Johnson & Eagly, 
2000; Rosenthal, 1994). To the extent that the standard deviation of the relatives is larger than 
that of the controls, Cohen’s ‘d’ will result in a more conservative estimate of effect size than 
Glass’ ‘d’. Mean effect sizes were calculated for factor comparisons by weighting each ‘d’ by the 
inverse of the conditional variance of ‘d’ (Shadish & Haddock, 1994). On occasion, Cohen’s ‘d’ 
was included in these calculations along with Glass’ ‘d’; use of both indices in this calculation 
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may result in an underestimation of the mean effect size. Cohen (1987) suggests the following 
guidelines for interpretation of effect size ‘d’: 0.2 = small, 0.5 = medium, 0.8 = large.  
1.2.2.1 Social-Interpersonal Symptoms. 
Index Relatives vs. Healthy Controls. 
Factor-level comparisons. Seven studies reported comparisons between first-degree 
relatives of schizophrenia patients and psychiatrically healthy controls; these data are presented 
in Table 2 (Appels, Sitskoorn, Vollema, & Kahn, 2004; Calkins, Curtis, Grove, & Iacono, 2004; 
Grove et al., 1991; Kendler et al., 1995; Kremen, Faraone, Toomey, Seidman, & Tsuang, 1998; 
Squires-Wheeler et al., 1997; Yaralian et al., 2000). The largest reported effect (d = 1.65), 
suggesting worse social-interpersonal functioning among relatives, came from a comparison of 
unscreened first-degree relatives and no-diagnosis controls, and thus could reflect inflated 
index/control differences (Grove et al., 1991). The other large effect (d = 1.10) was obtained by 
the New York High Risk Study (Squires-Wheeler et al., 1997). Their sample consisted only of 
offspring of schizophrenia patients, a sizeable minority of which will develop schizophrenia; 
therefore, elevated pathology among this sample of relatives could reflect “prodromal” effects. 
Methodologically, one of the most persuasive reports is from the Roscommon Family Study 
(Kendler et al., 1995), given the large sample size, moderate screening of relatives, and use of 
relatives of control probands to obtain a more representative control sample. This study reported 
moderate elevation of social-interpersonal symptoms in first-degree relatives compared to 
control relatives (d = 0.27 to 0.67)1
                                               
1 Effect sizes estimated from odds ratios reported by Kendler et al. (1995) utilized Cohen’s ‘d’ index of association 
(relative M – control M/pooled SD) (Cohen, 1987), and may underestimate effect size. 
. It is interesting that all non-significant effects were reported 
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by studies that used questionnaire-based assessment of SPD (Appels et al., 2004; Kremen et al., 
1998; Yaralian et al., 2000), perhaps a result of low sensitivity of these measures to detect social-
interpersonal symptoms among relatives. Although, Calkins et al. (2004) did find a moderate 
effect (d = 0.55), similar to the Roscommon Family Study, using a questionnaire measure. In 
sum, the results of these studies best support a medium effect of elevated social-interpersonal 
symptoms among first-degree relatives of schizophrenia patients compared to psychiatrically 
healthy controls.  
Symptom-level comparisons. Two of these studies also reported social-interpersonal 
symptom-level comparisons between first-degree relatives of schizophrenia patients and healthy 
controls. Yaralian et al. (2000) reported significant elevation among relatives only for paranoid 
ideation, whereas Calkins et al. (2004) reported significant effects for elevated social anxiety, no 
close friends, and constricted affect, but no differences for suspiciousness. Overall, the results 
from Calkins et al. are more consistent with the medium effect suggested by the factor 
comparisons. Possibly, the non-significant effects reported by Yaralian et al. were a result of 
limited power due to the small number of index relatives in their sample. Of course, since the 
majority of studies did not report comparisons for individual social-interpersonal symptoms, the 
effects detected by Calkins et al. are hardly conclusive and thus await further study. 
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Index Relatives vs. Other Diagnoses. 
Factor-level comparisons. Table 2 also presents comparisons between first-degree 
relatives of schizophrenia patients and relatives of patients diagnosed with affective disorder or 
alcohol/drug abuse on social-interpersonal symptoms of SPD. Factor-level comparisons with 
relatives of affective disorder patients were reported by three studies (Kendler et al., 1995; 
Schurhoff, Laguerre, Szoke, Meary, & Leboyer, 2005; Squires-Wheeler et al., 1997). The largest 
effect (d = 0.87) was reported by Kendler et al. (1995) indicating elevated suspiciousness among 
index relatives compared to affective disorder relatives. However, neither of the other two 
studies reported on suspiciousness. In contrast, Schurhoff et al. (2005) reported no difference 
between index relatives and relatives of bipolar patients; although, of the three studies, this was 
the only one to use questionnaire-based assessment. This study also limited the comparison 
group to relatives of bipolar disorder patients which, given the proposed etiologic similarities 
between schizophrenia and bipolar disorder, may have increased similarity between the relative 
groups. Finally, Kendler et al. (1995) and Squires-Wheeler et al. (1997) both reported small to 
medium effect sizes indicating elevated symptoms of negative schizotypy in index relatives 
versus affective disorder relatives, although as noted above, comparisons with offspring of 
schizophrenia patients as reported in the New York High Risk Study (Squires-Wheeler et al., 
1997) may tend to inflate group differences. Taken together, the few available results suggest a 
small to medium effect of elevated social-interpersonal factor symptoms in relatives of 
schizophrenia patients compared to affective disorder relatives. Lastly, one study reported factor-
level comparisons between index relatives and relatives of individuals diagnosed with 
alcohol/drug abuse, and found no difference between groups (d = 0.01) (Yaralian et al., 2000). 
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Any conclusions regarding relatives of alcohol/drug abuse patients of course await additional 
studies. 
Symptom-level comparisons. Two studies conducted symptom-level comparisons 
between first-degree relatives of schizophrenia patients and relatives of affective disorder 
patients. Torgersen et al. (1993) reported small to medium effects of greater social anxiety (d = 
0.32) and inappropriate affect (d = 0.30) in index relatives; similarly, Lyons et al. (1994) 
reported that index relatives were significantly elevated on inadequate rapport (which was 
replaced by “inappropriate affect’ when the DSM-III was updated to DSM-III-R) compared to 
affective disorder relatives. Together, the results of these two studies thus support a small to 
medium effect of elevated inappropriate affect in index relatives compared to affective disorder 
relatives, although additional studies are needed to confirm this finding. Comparisons between 
index relatives and relatives of individuals diagnosed with alcohol/drug abuse again were 
reported only by Yaralian et al. (2000). Their results suggested a medium to large effect of 
heightened paranoid ideation among index relatives that approached significance (d = 0.60; 
p=.06). This finding of course awaits replication. 
1.2.2.2 Cognitive-Perceptual Symptoms. 
Index Relatives vs. Healthy Controls.  
Factor-level comparisons. All of the studies listed in Table 2 also reported results 
pertaining to the cognitive-perceptual symptoms of SPD; these data are presented in Table 3. 
Two of the largest effects (d = 1.02; d = 0.51), suggesting elevated cognitive-perceptual 
symptoms among first-degree relatives, were reported by Yaralian et al. (2000) and Grove et al. 
(1991), respectively. However, the samples of relatives in these studies were unscreened for 
 17 
psychiatric illness, which could have inflated index/control differences. Kremen et al. (1998) 
also reported a medium to large effect of elevated cognitive-perceptual symptoms (d = 0.65), 
particularly among male first-degree relatives; although this result does not appear inflated, it is 
unclear how comparable it is to results for mixed sex samples. Of the remaining results, the small 
elevations of cognitive-perceptual symptoms in relatives reported by Kendler et al. (1995) and 
Calkins et al. (2004) are the most convincing (d = 0.36 and d = 0.24, respectively). However, the 
significant, negative effect reported by Appels et al. (2004), suggesting less pathology among 
parents of schizophrenia patients compared to controls, is particularly striking. Theory regarding 
fitness effects would instead tend to predict elevated schizotypy among index parents, although 
perhaps this negative finding reflects parents’ unwillingness to endorse cognitive-perceptual 
symptoms of SPD. At this point, it is difficult to interpret or dismiss this negative effect. 
Considered together, current results seem to best support a small effect of elevated cognitive-
perceptual factor symptoms among index relatives compared to controls. 
Symptom-level comparisons. Three studies reported on cognitive-perceptual symptom-
level comparisons between first-degree relatives of schizophrenia patients and healthy controls.  
For unusual perceptual experiences, Yaralian et al. (2000) reported a large, although likely 
inflated (due to unscreened index relatives), positive effect (d = 1.02) indicating elevated 
symptoms in relatives compared to controls, whereas Calkins et al. (2004) found a small positive 
effect (d = 0.38). Yaralian et al. (2000) also reported elevated ideas of reference (d = 0.87) and 
paranoid ideation (d = 0.75) among relatives, but again perhaps index/control differences were 
inflated. In contrast, Appels et al. (2004) observed a significant negative association for unusual 
perceptual experiences and magical thinking, suggesting that index relatives endorse fewer of 
these symptoms than controls. As noted above, these results could perhaps reflect parents’ 
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reluctance to endorse cognitive-perceptual symptoms of SPD. At this point, any conclusions are 
difficult; a small effect of unusual perceptual experiences is perhaps most likely given these 
results. 
Index Relatives vs. Other Diagnoses. 
Factor-level comparisons. As can also be seen in Table 3, none of the three studies that 
compared first-degree relatives of schizophrenia patients and relatives of affective disorder 
patients on the cognitive-perceptual factor reported significant results. In contrast, the single 
comparison with relatives of individuals diagnosed with alcohol/drug abuse did find a significant 
elevation among index relatives (d = 0.79) (Yaralian et al., 2000). Thus, these results argue 
against differences between index relatives and affective disorder relatives on cognitive-
perceptual symptoms, but suggest that these symptoms may be elevated in index relatives 
compared to alcohol/drug abuse relatives. 
Symptom-level comparisons. Two studies reported individual cognitive-perceptual 
symptom comparisons between index relatives and relatives of affective disorder patients, and 
reported no group differences (Lyons et al., 1994; Torgersen et al., 1993). Yaralian et al. (2000) 
reported large, albeit non-significant, elevations on unusual perceptual experiences, ideas of 
reference, and paranoid ideation among index relatives compared to alcohol/drug abuse relatives. 
These results are generally congruent with results of cognitive-perceptual factor comparisons 
discussed above. 
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Disorganized Symptoms. 
Index Relatives vs. Healthy Controls.  
Factor-level comparisons. Most, but not all of the studies presented in Tables 2 and 3 
also reported results pertaining to the disorganized symptoms of SPD; these data are presented in 
Table 4. Kendler et al. (1995) reported the largest elevation on the disorganized factor among 
index relatives versus controls (d = 0.96). In their study, the disorganized factor included 
“cognitive slippage” and “odd speech”, but did not include “odd behavior”, perhaps contributing 
to the larger effect. Given possible screening-related inflation of index/control differences 
reported by Yaralian et al. (2000), the remaining studies support, at best, a slight elevation of 
disorganized SPD symptoms among relatives compared to controls (Appels et al., 2004; Calkins 
et al., 2004; Kremen et al., 1998); although use of questionnaire assessments may have limited 
sensitivity to detect these types of symptoms. It is worth noting that in the literature, the 
disorganized dimension of schizotypy is generally considered to be less “stable” than the social-
interpersonal and cognitive-perceptual factors. This is consistent with the variability of results 
for this factor (range: d = 0.17-0.96), and that two studies did not report a separate disorganized 
factor (Grove et al., 1991; Squires-Wheeler et al., 1997).  
Symptom-level comparisons. Two studies (Calkins et al., 2004; Yaralian et al., 2000) 
presented comparisons for individual disorganized symptoms and both reported non-significant 
findings. As noted, questionnaire assessments may have low sensitivity to disorganized speech 
and behavior. Overall, these results are consistent with minimal differences between first-degree 
relatives and controls, but cannot rule out possible elevation of disorganized symptoms in index 
relatives that are more easily detectable using interview measures.  
 20 
Index Relatives vs. Other Diagnoses. 
Factor-level comparisons. Table 4 also presents the results of comparisons between first-
degree relatives of schizophrenia patients and relatives of other psychiatric groups on the 
disorganized factor of SPD. Comparisons between relatives of schizophrenia patients and 
relatives of either affective disorder (Kendler et al., 1995; Schurhoff et al., 2005) or alcohol/drug 
abuse probands (Yaralian et al., 2000) failed to yield significant results, arguing against 
specificity of disorganized symptoms to liability to schizophrenia.  
Symptom-level comparisons. Two studies reported individual symptom comparisons 
between index relatives and relatives of affective disorder patients. Torgersen et al. (1993) found 
a significant, albeit modest, elevation of odd speech among index relatives (d = 0.30), whereas 
Lyons et al. (1994) reported no group differences. Yaralian et al. (2000) also found no 
differences between index relatives and alcohol/drug abuse relatives on individual disorganized 
symptoms. These results generally support no specificity of disorganized symptoms to 
schizophrenia liability. 
1.2.3 Summary of SPD Review. 
The data reviewed above indicate that social-interpersonal symptoms of SPD are moderately 
elevated among first-degree relatives of schizophrenia patients compared to psychiatrically 
healthy controls, and thus are potentially sensitive to liability to schizophrenia. Social-
interpersonal symptoms also may differentiate relatives of schizophrenia patients from relatives 
of affective disorder patients, but not from relatives of substance abuse probands, suggesting the 
possibility of limited specificity to schizophrenia liability. 
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Results support a small effect of cognitive-perceptual symptoms of SPD among first-
degree relatives of schizophrenia patients compared to healthy controls, suggesting some 
sensitivity to schizophrenia liability. Cognitive-perceptual symptoms do not appear specific to 
schizophrenia liability compared to affective disorders. Although, results tentatively suggest that 
cognitive-perceptual symptoms may differentiate index relatives from relatives of substance 
abuse patients. 
Lastly, current evidence supports a slight elevation of disorganized symptoms of SPD in 
index relatives compared to controls; however, a more substantial effect cannot be ruled out. 
Disorganization symptoms do not appear specific to schizophrenia liability compared to affective 
disorders or substance abuse, however.  
1.2.4 Limitations. 
The findings from this review could be consistent with possibility that some symptoms of 
schizotypy may correlate with familial liability to schizophrenia. However, there are critical 
limitations of the current literature that raise doubt about the validity of this association. 
First, for all of the available studies, index relative samples consisted only of first-degree 
relatives of schizophrenia patients. As described in our discussion on methodology, although 
first-degree relatives are extremely useful, they only provide one point of view. Extended 
families can provide additional information on the nature of liability to schizophrenia. 
Furthermore, although most studies did control for at least age and sex to minimize spurious 
group differences, only one study utilized relatives of control probands to improve 
representativeness (Kendler et al., 1995), and none of the studies made use of non-first-degree 
relatives as a comparison group. The addition of liability data from extended schizophrenia 
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families to data provided by first-degree relatives could lead to more confident conclusions 
regarding the relation between SPD symptoms and schizophrenia liability. 
A second limitation pertains to assessment of SPD. Half of the available studies relied on 
questionnaires to provide data on SPD symptoms. This limits conclusions foremost because of 
concerns that questionnaires are differentially sensitive across symptoms of SPD, requiring that 
data obtained from questionnaires be viewed with reservation. Furthermore, comparisons 
between questionnaire- and interview-based results are not straightforward, limiting the extent to 
which data across multiple studies can be evaluated.  
Third, results were reported only for phenotypic SPD factors (e.g., the social-
interpersonal factor) and related symptoms. This is problematic from the standpoint that to be 
useful in genetic studies, an endophenotype must be sensitive to as few schizophrenia risk genes 
as possible, and have as limited sensitivity to non-schizophrenia risk genes as possible. 
Sensitivity (i.e. power) is compromised to the extent that the endophenotype is itself genetically 
heterogeneous. Although the identified SPD factors represent phenotypically similar SPD 
symptoms, these phenotypic factors reflect both genetic and environmental effects on 
associations with schizophrenia liability. Thus, genetic homogeneity of phenotypic SPD factors 
is uncertain and correlations with genetic liability to schizophrenia cannot be adequately 
assessed.  
Data from genetically-related individuals permit estimation of the unique contributions of 
genetic and environmental effects on a particular variable (e.g., SPD symptom). A variable that 
is strongly influenced by genetic effects (i.e., high heritability) is ideal as this suggests minimal 
impact of environmental effects, although a highly heritable variable can still be genetically 
heterogeneous, including effects of both schizophrenia risk and non-risk genes. Phenotypic 
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covariation of observed variables among family members can be separated into genetic and 
environmental variance components. Cross-relative correlations of variables can be calculated 
and just as phenotypic factors are derived from a matrix of correlations among observed 
variables, genetic factors can be derived from a matrix of genetic variance correlations among 
relatives2
1.3 AIMS OF THE CURRENT STUDY. 
. As such, genetic variance and covariance among variables (e.g., SPD symptoms) can 
be represented in terms of a set of genetic factors (Boomsma & Dolan, 1998; Boomsma, 
Molenaar, & Orlebeke, 1990). SPD genetic factors thus would reflect genetic homogeneity 
among SPD symptoms, absent confounding effects of environmental variance, and consequently 
may be particularly sensitive to genetic liability to schizophrenia.  
Identification of endophenotypes (I. I. Gottesman & Gould, 2003; I. I. Gottesman & Shields, 
1972)] that correlate with familial liability to schizophrenia, and are maximally sensitive to a 
homogeneous subset of risk genes, is an important strategy for enhancing detection of genes that 
affect schizophrenia risk. Although a number of studies have compared relatives of 
schizophrenia patients with non-psychiatric controls on symptoms of SPD, there are substantial 
methodological limitations present in the current literature. Second, only a small number of 
studies have included comparisons with relatives from other diagnostic groups and comparison 
diagnoses are limited primarily to affective disorders, with only one report on substance abuse. 
                                               
2 Environmental factors also could be derived from environmental correlations in this manner. 
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Such a narrow selection of diagnostic comparison groups makes it difficult to discern the extent 
of any specificity to schizophrenia liability. 
This family study was designed to systematically examine associations between SPD 
symptoms and genetic liability to schizophrenia among non-psychotic relatives of schizophrenia 
probands, with the ultimate goal of evaluating the utility of schizotypal symptoms as 
endophenotypes in genetic studies of schizophrenia. Furthermore, this study addressed a number 
of the methodological limitations present in the literature to date, by 1) utilization of data from 
first through fourth-degree relatives of schizophrenia probands, 2) assessment of symptoms of 
SPD using the Structured Interview for Schizotypy (SIS; Kendler, Lieberman, & Walsh, 1989), 
which is currently regarded as the gold standard for assessment of SPD, 3) use of genetic factors 
and genetic factor scores to examine the association between schizotypy and genetic liability to 
schizophrenia, and 4) comparison with relatives of major depressive disorder and substance 
dependence probands. The following specific aims were addressed:  
1) Estimation of heritabilities of individual symptoms of schizotypal personality disorder 
(SPD), as assessed by the SIS; 
2) Calculation of genetic correlations between individual symptoms of SPD (SIS scales) and 
schizophrenia; 
3) Construction of genetically homogeneous and uncorrelated SPD factors; 
4) Estimation of heritabilities of these SPD genetic factors; 
5) Calculation of genetic correlations between the SPD genetic factors and schizophrenia; 
6) Calculation of genetic correlations between the SPD genetic factors and two additional 
psychiatric diagnoses represented in this sample, specifically major depressive disorder 
(MDD) and substance dependence.  
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2.0  METHOD. 
2.1 PARTICIPANTS. 
The participants in this study were 597 European-American, first- through fourth-degree 
relatives of 43 Schizophrenia or Schizoaffective Disorder, Depressed Type probands from 43 
multigenerational multiplex families, and 88 European-American non-psychotic control 
individuals demographically matched to the relatives. All participants provided written informed 
consent according to the guidelines of the University of Pittsburgh or University of Pennsylvania 
Institutional Review Boards, and were remunerated for their participation in the study and for 
travel expenses.  
2.1.1 Index Probands. 
Potential probands were identified through consumer and mental health organizations located in 
Pennsylvania, Delaware, Indiana, Kentucky, Michigan, New Jersey, Ohio, and West Virginia. 
Participating index probands were at least 18 years old, European-American, met DSM-IV 
diagnostic criteria for schizophrenia, and had at least one first-degree relative who also was at 
least 18 years old, European-American, met DSM-IV criteria for either schizophrenia or 
schizoaffective disorder, depressed type, and might be willing to participate. All diagnoses were 
established by consensus based on diagnostic interviews (see below). Each proband was further 
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required to have at least 10 first- to fourth-degree relatives who might be willing to participate. 
Potential probands were excluded according to the following criteria: unable to provide signed 
informed consent, unwilling to provide consent to contact family members, psychosis due to a 
substance use disorder, medication, medical/neurological condition, or pervasive developmental 
disorder by DSM criteria, existence of a medical condition that may cause neurocognitive 
deficits, IQ < 70, or lack of proficiency in English.  
2.1.2 Index Relatives. 
First- to fourth-degree relatives of each schizophrenia proband, who were 15 years of age or 
older at the time of recruitment and resided within the contiguous United States, were eligible for 
participation. Potentially eligible relatives were identified by the probands and other enrolled 
family members, and gave permission to be contacted by phone. Relatives were then contacted 
by an interviewer who provided information about the study and conducted a brief screening. 
Exclusion criteria were minimal: existence of a medical condition that may cause neurocognitive 
deficits, or lack of proficiency in English. Interviews were scheduled with those eligible relatives 
who agreed to participate. 
2.1.3 Control Probands. 
Non-psychotic, European-American individuals, age 18-84, who did not have a first-degree 
relative with a psychotic disorder, were eligible for inclusion in the control group. Recruitment 
procedures implemented at the University of Pittsburgh were designed to achieve a 
representative control group that was on average matched on age, sex, and location of residence 
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to the index pedigree members (probands and relatives) enrolled in the study. Age and sex 
matching was achieved by creating age bins (e.g., 18-20, 21-30, 31-40) and calculating the 
percentage of male and female family members within each bin. Age and sex recruitment targets 
necessary to achieve equivalent percentages for controls were then calculated. To match on 
location of residence, controls recruited at the University of Pittsburgh resided in one of the 
following five geographic regions, defined by telephone area code, from which the majority of 
index probands and relatives had been recruited: Pittsburgh, PA, Detroit, MI, Columbus, OH, 
Cleveland, OH, and Dayton, OH. Within these regions, all potential control individuals were 
initially contacted through random digit dialing by the University Center for Social and Urban 
Research (UCSUR) at the University of Pittsburgh.  
Interested individuals identified through the University of Pittsburgh completed a 
telephone screening to assess the following exclusion criteria: they or a first-degree relative had 
been diagnosed with a schizophrenia spectrum disorder or other psychotic disorder, recent 
exacerbation of non-psychotic psychiatric symptoms (evidenced by, for example, psychiatric 
hospitalization or a dose increase of psychiatric medication in the past month), electroconvulsive 
therapy in the past six months, treatment for alcohol or substance disorder in the past six months, 
medical condition that could produce psychiatric symptoms or neurocognitive deficits (e.g., 
Alzheimer’s disorder), history of head injury resulting in cognitive changes, or sensory or 
physical impairments that could interfere with completion of study measures. 
University of Pennsylvania controls were identified by approaching eligible individuals 
already known by the staff, meeting with their friends, and word of mouth.  These individuals 
were then screened either in person or over the phone. Exclusion criteria were: lifetime diagnosis 
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of a psychotic disorder, a history of psychotic disorders in the family, current treatment with 
psychotropic medication, or diagnosis of any neurological disorder. 
2.2 ASSESSMENTS. 
2.2.1 Diagnostic Assessment. 
Lifetime, multiaxial diagnoses based on DSM-IV criteria were established by consensus 
conference by licensed psychologists and psychiatrists who were blind to subject identity and 
group status (proband, relative, control). All interviews were conducted by trained interviewers 
with established reliability (kappa > 0.80), and under the supervision of the investigators. 
Reliability and training among interviewers was reviewed at semi-annual meetings. Interviewers 
were not blind to participant group status. Considerable effort was made to interview each 
participant in person, either at their home, at a community facility (e.g., a library), or at the 
interviewer’s office. On the rare occasions when an in-person appointment was not feasible, 
interviews were conducted by phone. If available, medical records were also reviewed. 
All participants were administered the Diagnostic Interview for Genetic Studies 2.0 
(DIGS) (Nurnberger et al., 1994) to assess current and lifetime psychiatric diagnoses and 
medical history, except controls recruited at the University of Pennsylvania. The DIGS 2.0 is a 
semi-structured interview designed to evaluate the presence of select Axis I psychiatric disorders 
based on DSM-IV diagnostic criteria. The following diagnoses were assessed: Schizophrenia, 
Schizoaffective Disorder, other psychotic disorder, Major Depressive Disorder (MDD), Bipolar 
Disorder, Dysthymia, Cyclothymia, Alcohol Abuse and Dependence, and Substance Abuse and 
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Dependence. Instead of the DIGS, the controls recruited at the University of Pennsylvania were 
administered a brief diagnostic screening interview to assess current and lifetime psychiatric and 
medical diagnoses, including substance use disorders, and family history of psychiatric illness. 
Lastly, at both sites at least one relative of each proband was administered the Family Interview 
for Genetic Studies (FIGS) (Maxwell, 1992) to gather additional diagnostic information about 
family members. 
2.2.2 Schizotypal Personality Disorder Assessment. 
Non-psychotic index relatives and University of Pittsburgh controls were assessed for symptoms 
of Schizotypal Personality Disorder (SPD) using a modified version of the Structured Interview 
for Schizotypy (SIS), which is included as part of the DIGS 2.0 (Kendler et al., 1989)3
The version of the SIS used in this study consists of two sections, the interview itself and 
post-interview behavior ratings. The interview is composed of 85 items across 14 scales: Social 
Isolation, Introversion, Sexual Anhedonia, Sensitivity (i.e. to remarks made about them by 
others), Social Anxiety, Restricted Emotion, Anger to Perceived Slights, Suspiciousness, 
. The SIS 
is a semi-structured interview specifically designed to assess schizotypal symptoms and is widely 
regarded as the most comprehensive interview available for this purpose. The SIS was developed 
and tested by Kendler and colleagues in the context of the Roscommon Family Study (K.S. 
Kendler et al., 1993).  
                                               
3 By convention, individuals meeting criteria for any psychotic disorder, including 
schizophrenia/schizoaffective probands and relatives diagnosed with a psychotic disorder, were excluded from the 
assessment of SPD.  
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Pathological Jealousy, Ideas of Reference: Being Watched, Ideas of Reference: Remarks, 
Magical Thinking, Psychotic-like Phenomena (i.e., thought disorder), and Illusions (auditory and 
visual). Each scale is composed primarily of multiple choice items, as well as some open-ended 
items for clarification. A global rating is generated for each scale to quantify the clinical 
significance of the respondent’s answers. All multiple choice items and global ratings in the 
interview are scored using a 0 – 6 Likert scale with the following anchors: 0 – no pathology, 2 – 
mild pathology/possible clinical significance, 4 – moderate pathology, 6 – marked pathology.  
The post-interview behavior ratings consist of 28 additional items designed to be rated 
following the interview based on the interviewer’s observation of the respondent. The following 
five scales (22 items) are rated and a global score is generated for each: Affect, Rapport, 
Suspiciousness/Guardedness, Organization of Speech/Thought, and Odd/Eccentric Behavior. 
The remaining six items assess Social/Interpersonal Functioning, Irritability, (respondent’s) 
Reaction to Interview Length, Openness in Responding, Level of Understanding of the 
Questions, and Overall Quality/Reliability of the Interview. All post-interview ratings are scored 
using a 0 – 4 Likert scale with the following anchors: 0 – good, 1 – fair to good, 2 – fair, 3 – 
poor, 4 – very poor. 
All of the 19 available SIS scales [Social Isolation, Introversion, Sexual Anhedonia, 
Sensitivity, Social Anxiety, Restricted Emotion, Affect, Rapport, Anger to Perceived Slights, 
Suspiciousness, Suspiciousness/Guardedness4
                                               
4 For clarity, “Suspiciousness/Guardedness” will be referred to as “Guardedness” from here forward. 
, Pathological Jealousy, Ideas of Reference: Being 
Watched, Ideas of Reference: Remarks, Magical Thinking, Psychotic-like Phenomena, Illusions, 
Organization of Speech/Thought, and Odd/Eccentric Behavior] and two of the additional post-
interview items (Social/Interpersonal Functioning and Irritability) were included in the current 
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study. The DSM-IV-TR criteria for SPD, the corresponding SIS scales, and characteristics 
associated with high scale ratings are presented in Table 5. The remaining four post-interview 
items (Reaction to Interview Length, Openness in Responding, Level of Understanding of the 
Questions, and Overall Quality/Reliability of the Interview) were not selected as they assess 
specific factors related to the interview experience, and are not intended to assess symptoms of 
SPD. For simplicity, the two post-interview items included in this study (Social/Interpersonal 
Functioning and Irritability) are referred to as “scales” from here forward to avoid confusion 
with the individual items that comprise the scales.  
2.2.2.1 SIS Scale Scores. 
An overall mean item score was generated for each SIS scale. Open-ended items were excluded 
as these did not yield a quantitative score. To maximize the number of quantitative items 
available for each scale, items missing responses due to the design of the SIS interview (i.e., 
items not clinically applicable to the participant were skipped) were coded as follows: items 
skipped do to absence of pathology were coded ‘0’; items skipped due to presence of marked 
pathology were coded ‘6’. Missing responses due to any other reason were coded as missing. 
Cases missing responses for more than 50% of the items in a particular scale were excluded from 
that scale, except due to the structure of the Introversion scale, cases missing responses for more 
than 60% of the items in this scale were excluded. Thus, for each scale, only cases with 50% or 
more of the items completed (40% or more for Introversion) were retained. For each case, scale 
scores [range: 0 (no pathology) to 6 (marked pathology)] were generated by dividing the sum of 
the completed items in that scale by the number of completed items.  
 32 
2.3 ANALYSES. 
All univariate analyses of heritability and bivariate analyses of genetic correlation among 
SIS scales and with schizophrenia were completed using SOLAR (Sequential Oligogenic 
Linkage Analysis Routines) (Almasy & Blangero, 1998) to accommodate the complex pedigree 
structure of the families included in this study. SOLAR is a comprehensive software package for 
genetic variance components analysis of quantitative-trait data in pedigrees of varying size and 
complexity. In SOLAR, all dichotomous variables (including diagnostic and trait variables) were 
modeled as threshold traits, all continuous variables were fit to a t-distribution, and analyses 
were corrected for proband-based ascertainment. It is important to note that in these analyses, 
estimates of heritability and genetic correlation assume that shared environment effects are zero 
or uncorrelated with degree of genetic relatedness. Analyses that did not involve examination of 
pedigree structure were conducted in SPSS and Mplus. 
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3.0  RESULTS. 
3.1 SAMPLE CHARACTERISTICS. 
3.1.1 Sample Selection and Attrition.  
Forty-three families consisting of 1610 pedigree members (43 index probands, 1567 first- to 
fourth- degree relatives) met the initial inclusion criteria described above; 676 of whom (43 
probands, 633 relatives) were enrolled as study participants. DIGS data were collected on 639 
pedigree members (42 probands5, 597 relatives6
                                               
5 One additional proband was diagnosed as schizoaffective, depressed type in the context of a previous study and 
was not administered the DIGS. 
); a mean of 14.9 individuals per family provided 
DIGS data. Although attempts to recruit large families were generally successful, some family 
members were not administered the DIGS assessment due to scheduling difficulties or the 
participant being lost to follow-up. Table 6 presents the distribution of individuals per family for 
whom DIGS data were available; the table does not include participants without DIGS data, 
many of whom completed assessments not included in this study (e.g., neuropsychological 
testing).  Table 7 presents the frequency distribution of the number of affected individuals 
(diagnosed with schizophrenia or schizoaffective disorder, depressed type) per family. In the 
case of four families, two affected individuals were initially identified, but upon later 
6 Includes 49 non-biological relatives (e.g., step-relatives, spouses) 
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consideration, consensus was that only one of these individuals met strict diagnostic criteria for 
schizophrenia or schizoaffective disorder, depressed type. As data had already been collected on 
these pedigrees, they were retained in the study.  
Two-hundred thirty unrelated, non-psychotic control individuals met inclusion criteria 
and were enrolled in the MGI study. DIGS data were collected on the 88 of these control 
individuals (all of whom were recruited at the University of Pittsburgh).  
3.1.2 Attrition Analyses. 
Table 8 presents the demographic characteristics of the final sample of index probands, 
relatives, and controls who were administered the DIGS and utilized in the current study. For the 
relatives, demographics are presented by degree of relationship to the proband and by generation 
within the family. Thirty-six enrolled relatives were not administered the DIGS and thus were 
excluded from this study. The 36 relatives who were not administered the DIGS were 
significantly older [mean (sd) = 56.1 (20.9)] (t = 3.06, p = .004) and more likely to be recruited 
from the University of Pennsylvania (97.2%) (χ2 = 22.48, p < .001) than the relatives from whom 
DIGS data were collected [mean age (sd): 45.2 (17.7)]. There were no significant differences in 
sex or education. 
One-hundred forty-two controls were not administered the DIGS, and thus were not 
included in this study. These controls (all recruited at the University of Pennsylvania) were 
significantly younger [mean (sd) = 40.6 (18.5)] than the 88 controls for whom DIGS data were 
available [51.9 (17.5)] (t = 4.56, p < .001). There were no significant differences in sex or 
education.  
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3.1.3 Group Demographic Comparisons. 
Only individuals for whom DIGS data were available were included in these and subsequent 
analyses. The index proband group completed significantly fewer years of education (t = -6.71, p 
< .001) than the control group; there was a non-significant trend for age (probands < controls, p 
= .051). The total index relative group also was less educated (t = -5.97, p < .001) and was 
significantly younger (t = -3.33, p = .001) than the control group. Sex was not significant for 
either group comparison. 
3.1.4 Group Clinical Characteristics. 
3.1.4.1 Index Probands. 
All 43 index probands were diagnosed with either schizophrenia (n = 41) or schizoaffective 
disorder, depressed type (n = 2). Of the 43 probands, two received an additional diagnosis of 
‘other mood disorder’ (e.g. substance-induced, due to a general medical condition) and 11 were 
diagnosed with a substance-related disorder (non-hierarchical). Clinical characteristics for the 
probands, as well as for the relatives and controls, are presented in Table 9. 
3.1.4.2 Index Relatives. 
Of the 597 index relatives for whom DIGS data were available, 60 were diagnosed with either 
schizophrenia (n = 51) or schizoaffective disorder, depressed type (n = 9). These diagnosed 
relatives, along with the index probands, comprise the group of 103 “affected” pedigree 
members; Table 7 provided the frequency distribution of affected pedigree members per family. 
For simplicity, from here forward we use the designation ‘schizophrenia’ to refer to the 103 
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“affected” individuals (diagnosed with schizophrenia or schizoaffective disorder, depressed 
type).  
As presented in Table 9, the following additional hierarchical diagnoses were represented 
in the index relative group (n): schizoaffective disorder, bipolar type (4); bipolar disorder (9); 
and other psychotic disorder (e.g., substance or medically related, psychosis-nos) (16). The 
following non-hierarchical, non-exclusive diagnoses also were represented among the index 
relatives: cluster A personality disorder (schizotypal, paranoid, or schizoid) (25); MDD (without 
psychotic features or diagnosis of a cluster A personality disorder) (110), MDD (with psychotic 
features or a diagnosis of a cluster A personality disorder) (10); other mood disorder (59); 
substance-related disorder (153); and dementia (2). 
3.1.4.3 Controls. 
As described above, the exclusion criteria for control individuals were relatively minimal 
to achieve a control group that was representative of the general population from which the index 
relatives were drawn. Table 9 presents the clinical characteristics of the control group. By 
design, none of the 88 control individuals met criteria for schizophrenia, schizoaffective 
disorder, depressed type, or any other psychotic disorder. The following non-hierarchical, non-
exclusive diagnoses were present among the 88 controls (n): MDD without psychotic features 
(24); other mood disorder (4); and substance-related disorder (16).  
3.1.5 SIS Group Characteristics. 
Of the 597 relatives who were administered the DIGS, SIS data were available for 480 
individuals. Relatives were excluded from SIS administration for the following reasons (n): 
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affected (schizophrenia or schizoaffective disorder, depressed type) (60), schizoaffective 
disorder, bipolar type (4), other psychotic disorder (16), MDD with psychotic features (3), and 
logistical problems unrelated to diagnosis (e.g., refusal, lost to follow-up) (24). SIS data from 
relatives with diagnoses of dementia (2) and bipolar disorder (8) also were excluded from the 
current analyses. Relatives diagnosed with a cluster A personality disorder (25) were retained in 
these analyses so as not to truncate the distribution of symptom severity assessed by the SIS. All 
88 University of Pittsburgh controls were administered the SIS. Table 10 presents the 
demographic and diagnostic characteristics of the 480 non-psychotic index relatives and 88 
University of Pittsburgh controls whose SIS data were included in the following analyses.  
3.2 SCALE DEVELOPMENT. 
As noted above, for relatives and controls, the overall score for each SIS scale was the mean 
rating of the completed items in that scale. Table 11 presents the frequency of cases with missing 
items and Table 12 presents descriptive statistics for each SIS scale. The internal consistency 
(Cronbach’s alpha) of each scale was examined in the combined sample (relatives and controls) 
to determine if the global rating for that scale should be included in the calculation of the overall 
scale score. Results indicated that for all scales, inclusion of the global rating increased internal 
consistency; thus, the global rating was included in the calculation of each scale score. The 
corrected item-total correlation between the global rating and the summed interview items in the 
combined sample was between 0.80 and 0.92 for all but three scales (Restricted Emotion = 0.70, 
Sexual Anhedonia = 0.62, Psychotic-like Phenomena = 0.51), which also argued for including 
the global ratings in the calculation of the total scale scores.  
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The distribution of SIS scale scores was inspected for outliers and all scores were deemed 
valid. Scale scores also were inspected for skewness. As expected, all individual SIS scales were 
significantly skewed among relatives, ranging between 0.7 and 3.7 (in relatives, SE for all scales 
= 0.1) (see Table 12). The scales that were found to be most skewed in the relatives were 
Guardedness (skewness = 3.3), Irritability (3.5), and Odd/Eccentric Behavior (3.7). All scales 
also were significantly skewed in the controls (range = 0.7 – 5.3, SE for all scales = 0.3), with 
the exception of Sensitivity (skewness = 0.3). In the controls, Guardedness, Irritability, and 
Odd/Eccentric Behavior were again among the most skewed (skewness = 4.2, 3.5, and 4.3, 
respectively), as were Rapport (3.0) and Organization of Speech/Thought (5.3).  
Mean differences between relatives and controls were tested for all individual SIS scales 
and results are presented in the last two columns in Table 12. As a group, relatives were rated on 
average significantly higher (more pathological) than controls on 14 of the 21 SIS scales: Social 
Isolation, Social/Interpersonal Functioning, Social Anxiety, Affect, Rapport, Anger to Perceived 
Slights, Suspiciousness, Guardedness, Pathological Jealousy, Ideas of Reference: Being 
Watched, Ideas of Reference: Remarks, Psychotic-like Phenomena, Organization of 
Speech/Thought, and Odd/Eccentric Behavior. 
Of the 480 relatives and 88 controls that comprised the final study sample, 96 relatives 
and 9 controls were missing data for at least one SIS scale. The Expectancy-Maximization (EM) 
algorithm in SPSS, using the student’s t distribution, was utilized to impute the missing SIS scale 
data. The EM imputation method is a maximum likelihood estimation procedure. It is generally 
robust to violations of normality and thus it is an appropriate imputation method for these data. 
Covariates were not included in the imputation procedure. Estimates of skewness for the imputed 
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scale scores were equivalent to the non-imputed scores for all scales in both the relatives and 
controls. 
Estimates of genetic correlation and heritability could not be calculated in SOLAR for six 
SIS scales (Suspiciousness, Ideas of Reference: Being Watched, Ideas of Reference: Remarks, 
Magical Thinking, Illusions, and Odd/Eccentric Behavior) due to failure to converge. 
Consequently, these six scales were dichotomized such that a rating of 0 (no pathology) was 
retained and any rating greater than 0 was given a score of 1. These six scales remained 
dichotomized for all subsequent analyses. Seven additional scales (Social Anxiety, Irritability, 
Anger to Perceived Slights, Pathological Jealousy, Guardedness, Rapport, and Psychotic-like 
Phenomena) also required dichotomization to complete one or more individual analyses. These 
scales can be assumed to be continuous, except where expressly noted that the dichotomized 
form was used. Dichotomized scales were modeled as threshold traits within SOLAR in the 
analyses that follow. Given the degree of skewness present in the continuous SIS scales, 
continuous data were fit to a t-distribution in SOLAR. 
3.3 COVARIATES. 
The following demographic and diagnostic variables were selected for use as possible covariates 
in subsequent analyses: age, sex, education, MDD (without psychotic features), and substance 
dependence (includes alcohol dependence). Since the effects of education and the diagnostic 
variables may not necessarily be spurious, analyses were run twice: first with only age and sex as 
covariates and a second time with education and the diagnostic variables also included. 
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3.3.1 Heritability of Covariates.  
“Heritabilities” of the demographic and diagnostic covariates were estimated in the combined 
pedigree (probands and relatives) and control sample, while correcting for age and sex 
(heritability for age corrected for sex and vice versa). Heritability (h2) indicates the proportion of 
variation that is due to genetic effects. In the case of the covariates, it is useful to know the 
proportion of genetic variation prior to controlling for these effects. As can be seen in Table 13, 
all covariates except sex demonstrated significant heritability (h2 = 0.27 to 0.61, p < .002). 
Although significant heritability was expected for education and the diagnostic variables, 
generally age would not be expected to be “heritable”. However, the pedigree structure of the 
sample resulted in the inclusion of a number of sibling pairs such that more closely related 
individuals tended to be more similar in age.   
3.3.2 Genetic Correlation of Covariates and Schizophrenia.  
The demographic and diagnostic covariates also were examined for “genetic correlations” with 
schizophrenia in the combined pedigree and control sample while adjusting for age and sex 
(Table 14). Genetic correlation (Rg) is an estimate of the proportion of genetic effects that are 
shared between two variables. Although sex was not “genetically” correlated with schizophrenia, 
a significant positive genetic correlation was found for age. Although not predicted, the pedigree 
structure of the sample is such that individuals more closely related to schizophrenia patients 
tended to be older compared to more distant relatives. Negative genetic correlations were found 
for education (Rg = -0.26, p = .012) and MDD (Rg = -0.50, p = .002), indicating that close 
relatives of schizophrenia patients received fewer years of education and were less likely to be 
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depressed than more remote relatives. Substance dependence was not significantly genetically 
correlated with schizophrenia.  
3.3.3 Covariates and SIS Scales. 
Correlations between the covariates and SIS scales in the combined relative and control sample 
were calculated next. As can be seen in Table 15, age, sex, and education were significantly 
negatively correlated with a number of SIS scales (52%, 38%, and 48% of the scales, 
respectively). This indicates that the responses of relative and control participants who were 
younger, male, and/or had fewer years of education tended to be rated as more pathological 
compared to the other participants. MDD and substance dependence were significantly positively 
correlated with 48% and 71% of the scales, respectively, indicating these diagnoses were 
associated with more pathological scale ratings. Finally, diagnosis of a cluster A personality 
disorder was significantly correlated with 90% of the scales, signifying that as expected, 
individuals with a diagnosis of a cluster A personality disorder were rated as more pathological 
on the SIS scales compared to individuals without such a diagnosis.  
3.4 INDIVIDUAL SIS SCALES. 
3.4.1 Heritability of SIS Scales. 
Heritability was estimated for each SIS scale in the combined pedigree and control sample. For 
each SIS scale, heritability was estimated first using age and sex as covariates, and then a more 
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conservative test was applied by taking into account all the covariates identified above: age, sex, 
education, MDD, and substance dependence. As can be seen in Table 16, when age and sex were 
entered as covariates, all scales showed significant heritability (h2 = 0.18 to 0.74, p < .010). 
When all demographic and diagnostic covariates were entered, the results did not substantially 
change (h2 = 0.19 to 0.76, p < .015). Heritability of a cluster A personality disorder diagnosis 
also was calculated, and was found to be significant (h2 = 0.64, p = .013).  
3.4.2 Genetic Correlation of SIS Scales and Schizophrenia. 
The genetic correlation with schizophrenia was estimated for each of the SIS scales in the 
combined pedigree and control sample. As in the analyses above, the genetic correlation first was 
estimated using age and sex as covariates; a more conservative test then was applied by 
controlling for all the demographic and diagnostic covariates (age, sex, education, MDD, 
substance dependence). As presented in Table 17, when age and sex were entered as covariates, a 
significant positive genetic correlation with schizophrenia was found for one scale, Guardedness, 
indicating that individuals closely related to a schizophrenia patient were more likely to be rated 
by interviewers as appearing guarded and suspicious during the interview. Trends towards 
significant negative genetic correlations with schizophrenia were found for Magical Thinking 
and Ideas of Reference: Watched. This suggests that individuals with a close relative with 
schizophrenia were less likely to report unusual beliefs, superstitions, and feeling scrutinized in 
public. Negative correlations for Magical Thinking and Ideas of Reference: Watched were 
unexpected findings, and perhaps reflect close relatives’ guardedness when asked about unusual 
thoughts, beliefs, and experiences. When all demographic and diagnostic covariates were 
entered, Guardedness remained significantly genetically correlated with schizophrenia and the 
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negative correlation between Ideas of Reference: Watched and schizophrenia attained 
significance. The genetic correlation of a cluster A diagnosis and schizophrenia also was 
calculated and contrary to hypotheses, cluster A personality disorder was not significantly 
genetically correlated with schizophrenia (Rg = 0.23).   
3.4.3 Intercorrelation of SIS Scales. 
3.4.3.1 Phenotypic. 
Bivariate correlations were calculated among all 21 SIS scales in the pedigree sample while 
controlling for age and sex. As can be seen in Table 18, the SIS scales are, as expected, highly 
intercorrelated. An exploratory factor analysis of the phenotypic intercorrelations of the SIS 
scales was performed in Mplus for the combined pedigree and control sample. Factor structure 
was extracted using unweighted least squares and Varimax (orthogonal) rotation was applied. 
Four interpretable phenotypic factors, accounting for 52% of the variance across scales, were 
identified using the Kaiser-Gutterman rule (eigenvalues > 1); this solution was consistent with 
the results of a scree test. Table 19 presents the correlations (loadings) of the individual SIS 
scales on the four SIS phenotypic factors. The first factor, “Observed Behavior”, consists of all 
seven SIS scales that are rated based on interviewer observation of the participant. The 
remaining three phenotypic factors, “Cognitive-Behavioral”, “Social-Interpersonal”, and 
“Paranoid” closely correspond to factor solutions identified in previous studies (A.J. Bergman et 
al., 1996).  
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3.4.3.2 Genotypic. 
To examine the proportion of genetic effects shared among the 21 individual SIS scales, 
bivariate genetic correlations were calculated next, and are presented in Table 20. These data 
indicate the scales on which participants’ ratings are correlated due to shared genetic factors. For 
example, ratings on Social Isolation and Introversion are positively phenotypically correlated 
(Table 18) and this relation is substantially influenced by genetic effects (Table 20).  
3.5 SIS GENETIC FACTORS. 
An exploratory factor analysis of the genetic correlations among SIS scales was performed in 
Mplus for the combined pedigree and control sample. As this factor analysis is based on genetic 
correlations, SIS scales that load strongly on the same genetic factor should be influenced, in 
part, by the same genetic effects. Factor structure was extracted using unweighted least squares 
and Varimax (orthogonal) rotation was applied. Six interpretable genetic factors were identified 
using the Kaiser-Gutterman rule and this solution was consistent with the results of a scree test. 
Together, the six genetic factors accounted for 87% of the genetic variance across SIS scales. 
The correlations (loadings) of the SIS scales with each of the six genetic factors are reported in 
Table 21.  
The first genetic factor presented in Table 21, “Paranoid Fears”, most strongly reflects 
the SIS scales Social Anxiety, Pathological Jealousy, Sensitivity, Psychotic-like Phenomena, 
Ideas of Reference: Remarks, Introversion, Suspiciousness, and Ideas of Reference: Watched. 
Anger to Perceived Slights also is correlated with this factor, although most strongly loads on the 
sixth factor (Unusual Beliefs). The combination of these scales suggests that this genetic factor 
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primarily represents paranoid fears and ideas of reference. As these scales are positively 
correlated with this factor, more pathological ratings on these scales are associated with higher 
factor scores.  
The scales that are primarily correlated with the second genetic factor, “Interpersonal 
Deficits”, are Organization of Speech/Thought, Rapport, Affect, Social/Interpersonal 
Functioning, Irritability, Guardedness, and Social Isolation. A few scales that loaded most 
strongly on the first factor (Paranoid Fears), such as Suspiciousness and Ideas of Reference: 
Watched, also show moderate correlation with the second factor. This factor seems best 
characterized as communication and interpersonal deficits. As these correlations are in the 
positive direction, SIS scale ratings of greater deficits are associated with higher scores on this 
factor. 
The third genetic factor, “Perceptual Distortions”, is most strongly represented by the 
unexpected combination of Sexual Anhedonia and Illusions, and is moderately correlated with 
Psychotic-like Phenomena. As these scales are negatively correlated with this factor, greater 
sexual anhedonia and increased perceptual distortions contribute to a lower factor score. For ease 
of communicating the results below, the sign of the Perceptual Distortions factor will be reversed 
in all the following such that from here forward, greater pathology on these SIS scales is 
associated with a higher Perceptual Distortions factor score. 
The fourth genetic factor presented in Table 21, “Restricted Emotions”, primarily 
consists of the Restricted Emotion scale, although Introversion, Affect, and Social/Interpersonal 
Functioning also positively correlate with this factor. As such, a higher factor score reflects more 
constricted expression of emotion/affect and social anhedonia. Illusions is negatively correlated 
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with this factor and as such, a lower rating on Illusions also contributes to a higher score on this 
factor.  
The fifth genetic factor, “Eccentric Behavior”, is correlated most strongly with 
Odd/Eccentric Behavior and also shows moderate correlation with Ideas of Reference: Remarks 
and Ideas of Reference Watched. This factor might best be described as eccentricities of thought 
and behavior. These scales are negatively correlated with this factor, so increased eccentric and 
unconventional thinking and behavior would contribute to lower factor scores. As with the third 
factor, the sign of the Eccentric Behavior factor also will be reversed; so from here on, greater 
pathology on these SIS scales is associated with a higher Eccentric Behavior factor score. 
Lastly, Anger to Perceived Slights and Magical Thinking are strongly correlated with the 
sixth genetic factor “Unusual Beliefs”; as is Ideas of Reference: Watched. Thus, this factor is 
predominantly characterized by hostility and atypical beliefs. As these scales are positively 
correlated with this factor, more pathological ratings are associated with higher factor scores. 
3.5.1 Calculation of Genetic Factor Scores. 
Genetic factor scores were estimated by the standard regression method (Loehlin, 2004), and 
calculations were completed using the SPSS Matrix-End Matrix function. Beta weights for each 
genetic factor were calculated from the genetic correlations among SIS scales (predictors) and 
the correlations of the SIS scales with the SIS genetic factors (that which is being predicted). 
Specifically, beta weights were derived by multiplying the inverse of the SIS scale genetic 
intercorrelation matrix by the matrix of correlations between the SIS scales and genetic factors 
using the formula: B = R-1S, where B is the matrix of beta weights, R is the matrix of genetic 
correlations among SIS scales, and S is the matrix of correlations between the SIS scales and the 
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genetic factors. The resulting matrix of beta weights is presented in Table 22. These beta weights 
subsequently were applied to the standardized observed SIS scale scores (z-scores) to yield 
predicted genetic factor scores on each of the six SIS genetic factors for each participant: F = 
Z*B, where F is the matrix of predicted genetic factor scores, Z is the matrix of standardized SIS 
scale scores, and B is the matrix of beta weights derived above (Loehlin, 2004). 
3.5.2 Intercorrelation of SIS Factor Scores. 
Bivariate genetic correlations were calculated among the six genetic factor scores in the 
combined pedigree and control sample while controlling for age and sex. As can be seen in Table 
23, the factor scores are genetically uncorrelated with each other as expected.  
3.5.3 Heritability of SIS Factor Scores. 
Heritabilities of the genetic factor scores were estimated for the six SIS genetic factors in the 
combined pedigree and control sample. As presented in Table 24, all factors were significantly 
heritable when controlling for age and sex (h2 = 0.25 to 0.58, p < .001) and when accounting for 
all demographic and diagnostic covariates (h2 = 0.25 to 0.57, p < .001).  
3.5.4 Genetic Correlations of SIS Genetic Factor Scores with Schizophrenia. 
Next, genetic correlations with schizophrenia were estimated for each of the SIS factors in the 
combined pedigree and control sample; these data are presented in Table 25. When age and sex 
were entered as covariates, significant negative genetic correlations with schizophrenia were 
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found for the Eccentric Behavior and Unusual Beliefs genetic factors.  A non-significant, 
positive genetic correlation with schizophrenia was observed for Interpersonal Deficits. 
Eccentric Behavior and Unusual Beliefs remained significantly genetically correlated with 
schizophrenia when the additional demographic and diagnostic covariates were entered.  
Taking into account the correlations between individual SIS scales and SIS genetic 
factors, as well as the beta weights applied to the scales, high factor scores on Eccentric Behavior 
predominantly reflect high ratings on Odd/Eccentric Behavior and Ideas of Reference: Remarks; 
elevated factor scores on Unusual Beliefs primarily reflect high ratings on Anger to Perceived 
Slights, Magical Thinking, and Ideas of Reference: Watched. As such, the negative genetic 
correlation between Eccentric Behavior and schizophrenia indicates that relatives who are 
closely related to an individual with schizophrenia tend to display less unconventional thinking 
and odd social behavior, and report fewer ideas of reference, compared to more distant relatives. 
Similarly, the negative genetic correlation between Unusual Beliefs and schizophrenia indicates 
that close relatives of schizophrenia patients tend to be low on hostility, and report fewer unusual 
beliefs, superstitions, or feelings of being scrutinized/singled out in public. Although 
unpredicted, these findings are consistent with the genetic correlations between the individual 
SIS scales and schizophrenia reported above. 
For Interpersonal Deficits, high scores are particularly indicative of elevated ratings on 
Organization of Speech/Thought, Rapport, Social/Interpersonal Functioning, Irritability, and 
Restricted Emotion. Although non-significant, the positive genetic correlation between 
Interpersonal Deficits and schizophrenia suggests that, as predicted, relatives who are closely 
related to an individual with schizophrenia tend to demonstrate more atypical speech, low 
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emotionality, constricted or suspicious affect, irritability, and social withdrawal compared to 
more distant family members.  
3.5.5 Genetic Correlations of SIS Genetic Factor Scores with Major Depressive Disorder. 
Next, genetic correlations with major depressive disorder (MDD, without psychotic features) 
were estimated for each of the SIS genetic factors in the combined pedigree and control sample, 
and are reported in Table 26. In contrast to the findings for schizophrenia, none of the genetic 
factors were significantly genetically correlated with MDD, although there was a non-significant 
negative genetic correlation for Perceptual Distortions. High scores on this factor reflect elevated 
ratings on Sexual Anhedonia, Illusions, and Psychotic-like Phenomena. This suggests that close 
relatives of an individual with MDD may tend to report less sexual anhedonia and fewer 
perceptual distortions than more remote relatives. 
3.5.6 Genetic Correlations of SIS Genetic Factor Scores with Substance Dependence. 
Genetic correlations with substance dependence also were calculated for each of the SIS genetic 
factors in the combined pedigree and control sample and these data are presented in Table 27. Of 
all six factors, the positive correlation with Paranoid Fears most closely approached significance. 
This factor is prominently characterized by high ratings of Social Anxiety, Pathological Jealousy, 
Sensitivity, Ideas of Reference: Remarks, Introversion, Suspiciousness, Social Isolation, and 
Illusions. As such, individuals who are closely related to someone with substance dependence 
may tend to report traits such as interpersonal hypersensitivity, distrust, and persecutory ideation.   
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4.0  DISCUSSION. 
The aims of this multigenerational, multiplex family study of schizophrenia were to: 1) estimate 
heritabilities of individual symptoms of schizotypal personality disorder (SPD), as assessed by 
the SIS, 2) calculate genetic correlations between individual SIS symptom scales and 
schizophrenia, 3) construct genetically homogeneous and uncorrelated SPD (SIS) factors, 4) 
estimate heritabilities of the genetic factors, 5) calculate genetic correlations between the genetic 
factors and schizophrenia, and 6) calculate genetic correlations between the genetic factors and 
two additional psychiatric diagnoses represented in our sample, specifically major depressive 
disorder (MDD) and substance dependence. This study also sought to improve on 
methodological constraints present in the previous literature. The findings can be summarized as 
follows, and are discussed in more detail below:  
1) All individual SIS scales were highly heritable, suggesting that endorsement of 
symptoms of SPD was strongly influenced by genetic effects. 
2a) The individual SIS scale, Guardedness, demonstrated a significant, positive genetic 
correlation with schizophrenia.  
2b) The individual SIS scale, Ideas of Reference: Watched, showed a significant, 
negative genetic correlation with schizophrenia; similarly, the Magical Thinking scale 
demonstrated a negative genetic correlation with schizophrenia that trended toward significance.  
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3) Six uncorrelated, genetic factors were constructed, accounting for 87% of the variance 
across all SIS scales.  
4) All genetic factors were highly heritable. Thus, the degree to which an individual was 
elevated on a particular factor was in part driven by genetic effects. 
5a) Two of the genetically distinct SIS factors, Eccentric Behavior and Unusual Beliefs, 
were significantly negatively genetically correlated with schizophrenia.  
5b) The Interpersonal Deficits genetic factor showed a positive, albeit non-significant, 
genetic correlation with schizophrenia.  
6a) None of the six SIS genetic factors were significantly genetically correlated with 
MDD. The highest non-significant (negative) correlation with MDD was found for Perceptual 
Distortions.  
6b) Likewise, none of the SIS factors showed a significant genetic correlation with 
substance dependence, although a positive trend was observed for Paranoid Fears.  
The following discussion is broadly organized into four sections. First, we discuss the 
current results in the context of prior studies of schizotypal traits and genetic liability to 
schizophrenia. Second, we address the implications of the current results for the potential utility 
of SPD symptoms as endophenotypes in genetic analyses of schizophrenia. Third, we discuss the 
limitations of this investigation, and fourth, we conclude with suggestions for future directions 
for this line of research. 
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4.1 SPD AND GENETIC LIABILITY TO SCHIZOPHRENIA. 
The results of this study address three important and interrelated topics pertaining to schizotypy, 
schizophrenia, and contributing genetic effects. The first topic discussed below is the nature of 
the genetic contribution to schizotypal personality traits in non-psychotic relatives, including the 
genetic factor structure of SPD traits. The second topic of discussion is the genetic relation 
between symptoms of SPD and the schizophrenia phenotype. Third, we discuss the genetic 
relation between SPD symptoms and non-psychotic, psychiatric diagnosis phenotypes. 
4.1.1 Genetic Effects on Symptoms of SPD. 
4.1.1.1 Individual SIS Scales.  
The significant heritabilities of the SIS scales indicate that characteristics of SPD observed 
among this sample of relatives of schizophrenia patients were strongly influenced by genetic 
effects; a finding that is consistent with the results of the few previous studies that have 
examined this question (Kendler & Hewitt, 1992; Torgersen, 1985). Furthermore, the results of 
the current study support strong genetic intercorrelations among particular groups of SIS scales, 
suggesting that multiple genetic factors contribute to the presence (or absence) of SPD 
symptoms. Thus, for example, there is a high likelihood that two closely related individuals (e.g., 
siblings) will endorse the same type and/or intensity of SPD symptoms. Additionally, if say, they 
both endorse Social Anxiety, then it is quite likely that both will endorse Introversion as well.  
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4.1.1.2 SIS Genetic Factors.  
To date, factor analyses of SPD symptoms among relatives of schizophrenia patients have been 
exclusively “phenotypic” in nature. Phenotypic factors reflect both genetic and environmental 
covariance, and thus confound the effects of genes and environment on symptoms of SPD. This 
study was the first to examine the genetic factor structure of schizotypy in an attempt to 
disentangle genetic and environmental effects. This exploratory factor analysis suggested that six 
genetic factors best accounted for the genetic variance among SIS scales, a solution similar to the 
five traits of “borderline schizophrenia” originally proposed by Kety et al. (Copenhagen 
Adoption Study; Kety et al., 1968). All six genetic factors were highly heritable. Furthermore, 
these factors were genetically uncorrelated with each other, and thus appear to reflect six distinct, 
latent genetic variables.  
Comparison with Previous Studies. 
It is interesting to compare the results of the novel genetic factor analysis reported here with the 
three SPD phenotypic factors most often reported (Social-Interpersonal, Cognitive-Perceptual, 
Disorganized) (A. J. Bergman et al., 2000), and similar to the phenotypic factors observed in this 
sample. First, the SPD symptoms previously observed to load on the “Social-Interpersonal” 
phenotypic factor7 primarily contributed to one of two genetic factors: Paranoid Fears or 
Interpersonal Deficits, with a tertiary loading on Constricted Affect for a small subset of 
symptoms.8
                                               
7 Social Isolation, Introversion, Sexual Anhedonia, Social/Interpersonal Functioning, Sensitivity, Social Anxiety, 
Restricted Emotion, Affect, Rapport, Anger to Perceived Slights, Suspiciousness (also reported to load on the 
Cognitive-Perceptual factor), Guardedness, Irritability, and Pathological Jealousy. 
 This divergence among social-interpersonal SPD symptoms may perhaps reflect two 
relatively distinct symptom clusters each influenced by different genetic effects. Presumably, in 
8 Although arguably, all six of the genetic factors each include an interpersonal component. 
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previous phenotypic factor analyses, these symptoms loaded together on the same factor due to 
environmental covariance.  
Second, of the SPD symptoms that typically characterize the “Cognitive-Perceptual” 
phenotypic factor9
Lastly, the “Disorganized” phenotypic factor
, all but one were at least moderately correlated with the Paranoid Fears 
genetic factor. The exception, Magical Thinking, was a substantial contributor only to Unusual 
Beliefs. It seems that most observed cognitive-perceptual symptoms of SPD do share a portion of 
their genetic variance, perhaps associated with paranoia.  
10
4.1.2 Genetic Association of SPD Symptoms and Schizophrenia. 
 is frequently noted in the literature as 
being less “stable” than the other two phenotypic factors, and is not consistently identified as a 
separate factor in phenotypic analyses of SPD symptoms (e.g., A. J. Bergman et al., 2000; Grove 
et al., 1991). Our results provide support for this observation as the two “disorganized” SIS 
scales, Organization of Speech/Thought and Odd/Eccentric Behavior, loaded on separate genetic 
factors (Interpersonal Deficits and Eccentric Behavior, respectively). As atypical speech and odd 
behavior appear to be genetically dissimilar, it is understandable that they do not always combine 
to form a separate phenotypic factor. 
We next focus our discussion on the results as they relate to the genetic correlations between 
SPD symptoms and schizophrenia. We first discuss the genetic relation of the individual SIS 
                                               
9 Ideas of Reference: Being Watched, Ideas of Reference: Remarks, Magical Thinking, Psychotic-like Phenomena, 
Illusions, and Suspiciousness. 
10 Organization of Speech/Thought and Odd/Eccentric Behavior 
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scales and schizophrenia. Second, we focus on the SIS genetic factors and schizophrenia, 
including potential explanations for the negative genetic correlations observed in this study.  
4.1.2.1 Individual SIS Scales.  
Three individual SIS scales, Guardedness, Magical Thinking, and Ideas of Reference: Watched, 
were found to be significantly (or nearly so) genetically correlated with schizophrenia. Foremost, 
Magical Thinking and Ideas of Reference: Watched were negatively correlated with 
schizophrenia. Both scales are based on the participants’ self-report responses to the interview 
items. As such, close relatives of individuals with schizophrenia, who presumably share a greater 
proportion of schizophrenia risk genes with a proband compared to more distant relatives, were 
less likely to report feeling singled out and scrutinized in public, and endorsed fewer culturally 
unusual beliefs and paranormal experiences compared to more distant relatives. These results 
suggest that referential ideation of being watched and magical thinking each share a portion of 
their genes with schizophrenia; although in both cases, the shared genetic effects that increase 
risk for schizophrenia contribute to lower reported levels of these SPD symptoms. 
Conversely, the Guardedness scale was significantly positively genetically correlated 
with schizophrenia. This scale is rated after the interview based on the interviewer’s observations 
of the participant. Thus, elevation on this scale indicates that the participant appeared particularly 
suspicious, vigilant, and guarded to the interviewer. This finding suggests that a portion of the 
genetic effects that increase risk for schizophrenia also contribute to higher levels of observed 
guarded behavior. Although it would seem plausible that observed heightened levels of 
guardedness would be consistent with an individual’s reluctance to divulge experiences of 
magical thinking and referential ideation, the Guardedness scale actually showed a significant 
positive phenotypic correlation with Magical Thinking and Ideas of Reference: Watched, and 
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was not genetically correlated with either scale. This suggests that the negative correlations 
observed for Magical Thinking and Ideas of Reference: Watched may not be due to elevated 
guardedness; however, the Guardedness scale reflects a small subset of behaviors and may not 
fully capture a participant’s willingness to self-report on these symptoms. 
It is unclear why the remaining individual SIS scales were not especially genetically 
correlated with schizophrenia. This is particularly surprising given the well replicated finding 
that as a group, relatives of schizophrenia patients are elevated on symptoms of SPD compared 
to normal controls. If relatives adopted a guarded response style throughout the interview, it 
likely would be reflected in all of the interview scales. However, as with Magical Thinking and 
Ideas of Reference: Watched, the Guardedness SIS scale actually showed significant positive 
phenotypic correlations, and non-significant genetic correlations, with the majority of the other 
SIS scales. Again, this suggests that the general lack of significant correlations between the SIS 
scales and schizophrenia may not be due to an overall guarded approach to the interview; 
however, as noted above, it must be cautioned that the Guardedness scale may have limited 
sensitivity in this area. 
4.1.2.2 SIS Genetic Factors: Negative Genetic Correlations. 
Eccentric Behavior and Unusual Beliefs. 
At the level of the SIS genetic factors, a significant negative genetic correlation with 
schizophrenia was found for the Eccentric Behavior and Unusual Beliefs factors. These results 
suggest that during the interview, close relatives of schizophrenia probands reported fewer 
atypical beliefs, superstitions, feelings of being scrutinized in public, and were observed by the 
interviewer to  display less unconventional thinking, odd social behavior, and hostility, compared 
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to more distant relatives. These results also indicate that a significant proportion of latent genetic 
effects that contribute to increased genetic risk for schizophrenia, also contribute to lower scores 
on the Eccentric Behavior and Unusual Beliefs factors. As these factors are not genetically 
correlated with each other, we can infer the presence of two genetically distinct latent variables, 
each of which separately influences schizophrenia liability.  
The negative direction of the significant genetic effects for the Eccentric Behavior and 
Unusual Beliefs factors, as well as the two individual SIS scales noted above (Magical Thinking 
and Ideas of Reference: Watched), was quite surprising. These genetic correlations indicate that 
as an individual’s genetic similarity (to a schizophrenia proband) increases, symptoms such as 
odd behavior, hostility, magical thinking, and referential ideation actually decrease. Although we 
cannot know for certain, there are a few plausible explanations for this unexpected finding that 
we address next. First, these negative genetic correlations may be spurious due to confounding 
variables in the data. Second, the observed negative genetic effects may accurately reflect the 
characteristics of this particular sample, but do not generalize to the general population of 
families of individuals with schizophrenia. Third, the negative genetic correlations observed in 
this sample also may be relevant to the general population of affected families. 
Negative Genetic Correlations are Spurious.  
Alpha error. It may be that the significant negative correlations we observed were simply 
a result of chance. A Bonferroni correction suggests assuming a significance threshold of .002 
for the 21 individual SIS scales, and .008 for the six SIS genetic factors. Utilizing these 
guidelines, all of the individual SIS scales but two (Sexual Anhedonia and Suspiciousness) and 
all six genetic factors would remain significantly heritable. However, none of the genetic 
correlations with schizophrenia would remain significant; therefore, Bonferroni corrected results 
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would indicate no relation between SPD symptoms and schizophrenia. Although Bonferroni 
correction is usually considered overly conservative with uncorrelated measures, it is possible 
that these significant negative genetic correlations with schizophrenia are due to chance.  
Age. As discussed earlier, in this sample age was positively “genetically” correlated with 
schizophrenia, and negatively correlated with a number of individual SIS scales, including Ideas 
of Reference: Watched. Thus, close relatives of schizophrenia probands tended to be older, and 
older relatives tended to score lower (less pathologically) on these SIS scales, which could 
spuriously induce the observed negative genetic correlations between the SIS scales (and SIS 
factors) and schizophrenia. However, all analyses reported above controlled for age. 
Furthermore, when we examined the genetic correlations of the scales and factors with 
schizophrenia without controlling for age, the results did not substantially change. As an 
additional assessment of age effects, we examined the genetic correlations between the SIS 
scales and schizophrenia separately for each generation and continued to obtain a negative 
association. Finally, the interaction term between age and generation was not significant. Thus, 
although age effects seem a very reasonable explanation for our findings, further analyses did not 
provide strong support for this possibility. 
Negative Genetic Correlations are Sample Specific. 
Multiplex family design. Another possible explanation for the negative genetic 
correlations with schizophrenia is that by recruiting multiplex pedigrees we may have selected 
for families in which inherited risk genes that could be expressed have already been expressed 
(as schizophrenia) in those members. This could be a result of a higher frequency of risk alleles 
in these multiplex families. Alternatively, these families may not differ from simplex families in 
frequency of risk alleles; but instead, a greater proportion of available risk genes may have been 
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expressed, perhaps due to elevated environmental stress. If a greater number of multiplex family 
members with risk alleles actually develop schizophrenia, then relatives who do remain well are 
likely to be particularly low in genetic liability. Given this, non-psychotic first-degree relatives 
from multiplex families actually may be relatively less symptomatic on measures of schizotypy 
compared to first-degree relatives from simplex families. This could tend to produce a negative 
genetic correlation between schizotypal symptoms and schizophrenia in the current sample.  
In contrast to this suggestion, the balance of theory and observation during the last two 
decades (I. I. Gottesman, 1991; I.I. Gottesman, McGuffin, & Farmer, 1987) supports a 
multifactorial model of schizophrenia liability which states that multiple genes, in combination 
with adverse environmental factors, form the basis of schizophrenia etiology. According to this 
model, liability to schizophrenia is distributed proportional to the number of genetic and 
environmental risk factors present. As liability to schizophrenia increases, so should the 
symptoms and deficits associated with this liability. Based on this model, non-psychotic relatives 
from multiplex schizophrenia families should have a higher degree of genetic loading for the 
disorder and as such, should display more symptoms of SPD than relatives from simplex 
families.  
A small number of studies have compared non-psychotic relatives from multiplex and 
simplex schizophrenia families, although no studies were identified that assessed symptoms of 
SPD. Seidman and colleagues (Faraone et al., 2000; Seidman et al., 2009; Seidman et al., 2003) 
published a series of reports on neuroanatomical and neuropsychological functioning in non-
psychotic (primarily first-degree) relatives from multiplex and simplex families of schizophrenia 
patients. These studies found that relatives from multiplex families had more neuroanatomical 
abnormalities, and greater neuropsychological deficits, compared to relatives from simplex 
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families. Furthermore, worse performance on neuropsychological tasks was correlated with 
greater neuroanatomical abnormalities among multiplex, but not simplex families. Together, this 
evidence indicates that relatives from multiplex families do show significantly more 
abnormalities than relatives from simplex families, at least on neuroanatomical and 
neuropsychological measures, suggesting that ascertainment of multiplex families is unlikely to 
result in the negative genetic correlations with schizophrenia observed in this study. 
Negative Genetic Correlations are Valid. 
Systematic underreporting. Finally, as suggested above, a plausible explanation for the 
negative genetic effects observed for Eccentric Behavior and Unusual Beliefs is that during the 
interview, first-degree relatives were especially likely to underreport unusual ideas, beliefs, and 
behavior: symptoms that they perhaps associated with their ill relative. First-degree relatives in 
particular tend to be very familiar with psychotic symptoms given the experience of having a 
child, sibling, or parent with schizophrenia. As genetic relatedness to a schizophrenia proband 
and familiarity with psychotic symptoms decrease, underreporting of unusual thoughts and 
behavior may in turn become increasingly rare. This situation would tend to produce a negative 
genetic correlation between the more “unusual” symptoms of schizotypy (e.g., magical thinking) 
and schizophrenia. Furthermore, close relatives may have tended to underreport on the SIS as a 
whole, which would offer a reasonable explanation for the non-significant results obtained for 
the other SIS genetic factors and individual SIS scales.  
In the current study, the Interpersonal Deficits genetic factor (which contained the 
Guardedness SIS scale that was based on interviewer rating) was neither genetically nor 
phenotypically correlated with the Eccentric Behavior or Unusual Beliefs factors, which does not 
add support for underreporting as a possibility. However, the Interpersonal Deficits factor may 
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not completely capture guardedness during the interview and as such, may not be an infallible 
indicator of reluctance to divulge information.  
There is a small literature concerning unusual beliefs and behaviors among first-degree 
relatives of schizophrenia patients that is relevant to this discussion. In our earlier review of SPD 
symptoms, results supported just a small effect of (elevated) cognitive-perceptual symptoms 
among first-degree relatives of schizophrenia patients compared to controls. One study (Appels 
et al., 2004) reported a negative association, suggesting that parents of schizophrenia patients 
endorsed significantly fewer unusual experiences and beliefs compared to controls; although the 
cause of this finding is unclear.  
The Chapman Perceptual Aberration Scale (Chapman, Chapman, & Raulin, 1978) also 
has been used to compare first-degree relatives of schizophrenia patients and controls, and has 
been reported to correlate strongly with cognitive-perceptual symptoms of SPD in relatives 
(Clementz, Sweeney, Hirt, & Haas, 1991). Clementz, Grove, Katsanis, and Iacono (1991) and 
Katsanis, Iacono and Beiser (1990) both reported that non-psychotic first-degree relatives scored 
lower (less pathological) than controls on the Perceptual Aberration Scale, despite scoring as 
expected (less pathological than probands, but more-so than controls) on other Chapman scales 
(Social Anhedonia and Physical Anhedonia; Chapman, Chapman, & Raulin, 1976). Docherty 
and Sponheim (2008) and Glatt, Stone, Faraone, Seidman, and Tsuang (2006) also reported no 
differences between first-degree relatives and controls on the Perceptual Aberration Scale [and 
the Magical Ideation Scale (Chapman, Chapman, Kwapil, Eckblad, & Zinser, 1994)], despite 
relatives being elevated on social and physical anhedonia. 
Finally, a few investigations used bidirectional personality inventories in their assessment 
of relatives of schizophrenia patients. Gonzalez-Torrez et al. (2009) assessed schizophrenia 
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probands, their first-degree relatives, and controls using the Spanish version of the Temperament 
and Character Inventory (TCI; Cloninger, 1994). They reported that on the Novelty-Seeking 
temperament dimension, relatives tended to endorsed lower novelty-seeking compared to 
controls (p = .081), yet did not differ on the other temperament and character dimensions. 
Berenbaum, Taylor, and Cloninger (1994) also found no differences between relatives and 
controls on traits of Control, Harm Avoidance, or Traditionalism as assessed by the 
Multidimensional Personality Questionnaire (MPQ; Tellegen, 1982). 
Together, these results indicate that close relatives of schizophrenia probands may not 
differ from, or may actually endorse less pathology than controls on symptoms such as magical 
thinking and ideas of reference. These reports thus corroborate that low ratings on these SPD 
symptoms for close relatives are not unique to this study. Therefore, it may be the case that the 
Eccentric Behavior and Unusual Beliefs genetic factors are sensitive to underreporting among 
relatives of schizophrenia patients, and thus could be analogous to the K scale (defensive 
underreporting) on the Minnesota Multiphasic Personality Inventory (MMPI). 
4.1.2.3 SIS Genetic Factors: Positive Genetic Correlations. 
Interpersonal Deficits. 
In contrast to Eccentric Behavior and Unusual Beliefs, the Interpersonal Deficits genetic factor 
showed a positive, albeit non-significant, genetic correlation with schizophrenia. This suggests 
that during the interview, close relatives of schizophrenia probands were somewhat more likely 
to display atypical speech, appear disconnected or irritated with the interviewer, and endorse 
constricted affect or lack of emotionality compared to more remote family members. This 
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finding is congruent with observations of elevated schizotypal social-interpersonal deficits 
among relatives of schizophrenia patients compared to non-relatives noted in our earlier review.   
Although not significant in the current study, we draw attention to this positive genetic 
correlation between Interpersonal Deficits and schizophrenia in light of accumulating evidence 
that social deficits may be an important piece of the genetic liability puzzle. First, prospective 
and retrospective studies consistently find that schizophrenia patients display greater social 
deficits and worse social adjustment in childhood and adolescence (prior to psychosis onset), 
compared to patients with affective disorders, healthy siblings, and controls (Cannon et al., 1997; 
Tarbox & Pogue-Geile, 2008; Willinger, Heiden, Meszaros, Formann, & Aschauer, 2001). 
Second, the level of social functioning attained prior to psychosis onset is an important correlate 
of individual variation in illness course and outcome (poor social functioning in childhood and 
adolescence tends to be associated with greater illness severity in adult schizophrenia patients), 
and this association tends to be stronger for schizophrenia than other psychiatric illnesses 
(Bromet, Harrow, & Kasl, 1974).  
Although speculative, the results of the current study suggest the possibility of shared 
genetic effects that elevate interpersonal deficits and increase risk for schizophrenia, and thus 
offer additional support for an association between social deficits and liability to schizophrenia. 
However, it remains unclear why the Interpersonal Deficits factor fell short of reaching 
significance in this study, but perhaps was a result of systematic underreporting by close 
relatives. 
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4.1.3 Genetic Association of SPD Symptoms and MDD and Substance Dependence. 
None of the six genetic factors were significantly genetically correlated with MDD. The highest 
non-significant (negative) correlation with MDD was found for Perceptual Distortions. Of note, 
MDD and schizophrenia were negatively genetically correlated, which would tend to inflate 
negative genetic correlations between MDD and the SIS genetic factors. This is not of particular 
concern here given the non-significant results. Likewise, none of the genetic correlations 
between the genetic factors and substance dependence reached significance, although a positive 
trend was observed between substance dependence and Paranoid Fears. As substance 
dependence was not genetically correlated with schizophrenia in this sample, inflation of results 
due to increased liability to schizophrenia does not seem likely.  
Overall, it seems likely that genes contributing to liability to MDD do not substantially 
overlap with genes that influence SIS genetic factor scores. Similarly, genes that elevate risk for 
substance dependence are likely not shared with those that affect SIS genetic factor scores. The 
possible exception is Paranoid Fears, which may share a proportion of genetic effects with 
liability to substance dependence. Of course, replication of these results in general population 
samples of MDD and substance dependence probands and their relatives would clarify 
generalizability of these results.  
4.2 SCHIZOTYPY AND THE SEARCH FOR SCHIZOPHRENIA RISK GENES. 
To be most useful in genetic studies of schizophrenia, an endophenotype (I. I. Gottesman & 
Gould, 2003; I. I. Gottesman & Shields, 1972) should 1) be as sensitive as possible to individual 
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genes that affect risk for schizophrenia and 2) correlate with genetic liability to schizophrenia in 
the absence of psychosis. The current study attempted to address these requirements with the 
goal of evaluating symptoms of SPD as potentially useful endophenotypes. Prior to considering 
the direction of the effects, we first examine the overall fit between the current results and these 
criteria. We then address the impact of the observed negative genetic correlations on this fit. 
4.2.1 Comparison of Results to Endophenotype Criteria. 
The six SIS genetic factors were obtained from genetic correlations among SIS scales and were 
not genetically correlated with each other; therefore, each factor reflects a distinct, homogeneous 
set of latent genetic effects shared by a particular subset of SIS scales. Three of the SIS genetic 
factors, Eccentric Behavior, Unusual Beliefs, and Interpersonal Deficits, also demonstrated 
moderate to strong genetic correlations with schizophrenia among non-psychotic relatives. As 
such, each of these three genetic factors is sensitive to distinct, homogeneous subsets of genes 
that contribute to genetic liability to schizophrenia in this sample (i.e., “risk genes”); although 
Eccentric Behavior and Unusual Beliefs were negatively associated with schizophrenia (see 
below) and Interpersonal Deficits showed a non-significant trend. Furthermore, these three 
genetic factors were not genetically correlated with liability to MDD or substance dependence, 
suggesting a degree of specificity to schizophrenia risk genes. Of course, the specific genes 
represented by these factors, and the degree to which they influence risk for schizophrenia, 
remain unknown.  
Although quite heritable, the majority of individual SIS scales were not strongly 
genetically correlated with schizophrenia in this sample. Thus, as separate phenotypes, individual 
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symptoms of SPD are unlikely to be useful in genetic studies, with the possible exception of 
Guardedness.  
In sum, the current study provides evidence that the SPD genetic factors Eccentric 
Behavior, Unusual Beliefs, and perhaps Interpersonal Deficits as derived from the SIS, are a) 
sensitive to a “homogeneous” subset of genes that affect risk for schizophrenia and b) correlate 
with genetic liability to schizophrenia in the absence of psychosis, and more strongly correlate 
with schizophrenia liability than with liability to MDD and substance dependence. Therefore, 
these symptoms of SPD perhaps could be useful endophenotypes, at least in regards to these 
criteria. Of course, there are a number of issues that await clarification. For example, the degree 
of genetic homogeneity present within each factor cannot be determined in this study. As yet, 
there also are no guidelines by which to determine the level of genetic homogeneity necessary 
for an endophenotype to be useful. 
4.2.2 Directionality of Genetic Correlations. 
This leads to the next crucial question: can genetic factors that are negatively genetically 
correlated with schizophrenia risk be useful in genetic studies? To reach a conclusion, first it 
must be determined if the apparent negative genetic correlations of Eccentric Behavior and 
Unusual Beliefs with schizophrenia are indeed valid, replicable, and systematic findings that are 
not unique to this multiplex sample. If replicated, the preceding discussion suggests that 
underreporting by close relatives would be the most plausible explanation for these negative 
genetic correlations. As such, among non-psychotic relatives, underreporting of unusual ideas, 
beliefs, and behavior appears to be significantly (and positively) genetically correlated with 
schizophrenia.  
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The Eccentric Behavior and Unusual Beliefs genetic factors thus appear to be sensitive 
indexes of shared genetic effects between underreporting on these particular symptoms and 
liability to schizophrenia. In addition to odd beliefs and behavior, these indexes may be sensitive 
to genetic effects on underreporting throughout the SIS interview. As noted above, these factors 
could be conceptualized as comparable to the MMPI K scale, which is a sensitive measure of 
underreporting on the MMPI. Furthermore, these indexes appear to be relatively specific to 
underreporting among family members of schizophrenia patients, at least compared to relatives 
of MDD and substance dependence patients. Given the methodological strengths of this study, 
the evidence suggests that Eccentric Behavior and Unusual Beliefs may have potential to be 
useful endophenotypes of schizophrenia. Of course, future replications are needed. 
4.3 LIMITATIONS. 
4.3.1 Sample. 
First, although the multiplex pedigree sample utilized in this study offers a number of 
exceptional benefits and opportunities for statistical genetic analyses, large multiply affected 
families represent a minority of those families that include an individual with schizophrenia. In 
fact, the majority of individuals with schizophrenia do not have any relatives with schizophrenia 
or a spectrum disorder (such as SPD). As such, comparisons between our results and those 
obtained from simplex family studies are not straightforward. In addition, interviewers were not 
blind to group status, and often provided SIS ratings for multiple individuals from the same 
family. 
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A second, similar issue pertains to the genetic correlations between the SIS genetic 
factors and MDD and substance dependence. As the individuals in our study with diagnoses of 
MDD or substance dependence were also relatives of schizophrenia patients, generalizability of 
these results should remain tentative until they can be replicated in a general population sample 
of individuals with these diagnoses. 
Third, given the age range of our pedigree sample (15 – 85), it is important to be aware 
that a proportion of the younger relatives may convert to psychosis subsequent to being 
interviewed. This concern may be especially relevant for male first-degree relatives under 25 and 
female first-degree relatives under 30, as they are at highest overall risk for schizophrenia. In this 
sample, 6% of male first-degree relatives were younger than age 25, and 14% of female first-
degree relatives were younger than age 30, at the time they were interviewed. Thus, taking final 
diagnostic status into consideration, a notable minority of male and female non-psychotic 
relatives included in this study may be misclassified as “unaffected”, and in actuality belong to 
the “affected” group. This error would tend to inflate pathology, particularly among more closely 
related individuals, and increase the chance that positive genetic correlations between SIS 
genetic factors (and scales) would be erroneously identified. Given the negative correlations 
reported above, misclassification does not appear to be a particular concern in this study.  
4.3.2 Proband Heterogeneity. 
As indicated above, the SIS was not administered to individuals with a psychotic diagnosis. 
Consequently, SIS scale scores and genetic factor scores were not available for our sample of 
“affected” participants. Although analyses were planned and executed with this characteristic of 
the data in mind, this study was not able to calculate genetic correlations or perform genetic 
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factor analyses to directly compare components of genetic variance of SPD symptoms among 
probands, relatives, and controls.  
On a related point, although this study takes a considerable step towards disentangling 
genetic and environmental covariance and reducing genetic heterogeneity of SPD symptom 
phenotypes, it was not possible to examine and minimize heterogeneity within the schizophrenia 
diagnosis phenotype itself, due to the small sample size of affected individuals. The polygenetic 
etiology of schizophrenia has been a significant hurdle for both molecular and behavioral genetic 
studies, and likewise is an issue that complicates interpretation of the current results.  
Finally, the family design of this study prevented the separate examination of effects that 
were due to genes and those that were due to shared environmental effects. As in the case of twin 
studies, this family study presumes no correlation between genetic effects and shared 
environmental effects. In this sample, it is thus assumed that shared environmental effects are 
either absent, or uncorrelated with degree of genetic relatedness to schizophrenia.  
4.4 FUTURE DIRECTIONS. 
The preceding discussion raises some interesting issues that could be pursued in future 
investigations. Foremost, the current results of course require replication to establish that the 
observed genetic correlations are not, in actuality, spurious. Second, a particularly frustrating 
limitation of this and many previous studies is the effect of genetic heterogeneity of the 
schizophrenia phenotype. Perhaps a useful next step would be to separate the schizophrenia 
phenotype into more genetically homogeneous components, as done here with SPD symptoms. 
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This strategy may help reduce the genetic “noise” within the schizophrenia phenotype and 
improve sensitivity to detect important associations.  
A few studies have divided schizophrenia by positive and negative symptoms 
(phenotypes), and examined the association between these phenotypic “subgroups” of 
schizophrenia and SPD symptoms in relatives. For example, Fanous, Gardner, Walsh, and 
Kendler (2007) examined the relation between positive and negative symptoms in schizophrenia 
probands and SPD symptoms in first-degree relatives. They reported that negative symptoms of 
schizophrenia probands predicted suspicious behavior, odd speech, social dysfunction, and 
negative symptoms of SPD among first-degree relatives, and there was a trend for proband 
positive symptoms to predict positive schizotypal symptoms. Additionally, Baron, Gruen, and 
Romo-Gruen (1992) examined the association between risk for SPD in first-degree relatives and 
the predominant symptoms (positive or negative) experienced by the probands. They found that 
elevation of positive symptoms among probands, regardless of the level of negative symptoms, 
was the best predictor of SPD in relatives. Given the promise of this strategy using 
phenotypically-determined subgroups, dividing schizophrenia into genetic components could be 
particularly informative for guiding the search for schizophrenia risk genes.  
Third, the measurement of schizotypal personality traits could provide an opportunity to 
improve sensitivity and specificity of these symptoms to liability to schizophrenia. As discussed 
earlier, the type of instrument (interview or questionnaire) used to assess SPD symptoms can 
affect the outcome and interpretation of results. Furthermore, all of the currently available 
measures evaluate symptoms of SPD exclusively on unidirectional scales. This understandably 
reflects the long held convention of diagnosing personality disorders as one would Axis I 
disorders, compared to using a more dimensional approach. This unidirectional approach seems 
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particularly true for measures of Cluster A personalities, perhaps because the associated traits 
seem outside the range of “normal” personality characteristics.  
Given the findings of this and other studies, bidirectional measures could provide the 
opportunity to more accurately examine the range of schizotypy traits, perhaps confirming 
unidimensionality, and evaluate their specificity to schizophrenia. In addition, if measures of 
schizotypal personality traits were extended to include the full range of their potential 
expression, it would provide a more complete picture of schizotypy among relatives of 
schizophrenia patients and perhaps offer additional insight into how liability to (or protection 
from) schizophrenia is expressed. Lastly, genetic factors generated from the full range of 
schizotypy traits would likely be more sensitive and specific to shared genetic effects with 
schizophrenia compared to the genetic factors identified in this study. 
Finally, the results of this investigation suggest that the Eccentric Behavior, Unusual 
Beliefs, and (perhaps) the Interpersonal Deficits genetic factors may be particularly sensitive 
(and specific?) to genetic effects that increase risk for schizophrenia, perhaps more so than some 
of the traditionally (phenotypically) identified risk markers. Thus, following the endophenotype 
strategy and in accordance with the primary motivation for this study, these genetic factors could 
be applied to genome-wide bivariate linkage analyses of schizophrenia. Taking this step would 
allow the utility of these particular genetic factors to be evaluated, as well as provide additional 
validation for the novel strategy of endophenotype design presented in this paper. 
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5.0  CONCLUSION. 
This study examined the nature of schizotypy among multigenerational, multiplex schizophrenia 
families and addressed a number of the methodological limitations present in the literature to 
date. Genetic schizotypy factors and factor scores were derived, using a novel application of 
genetic factor analysis, and evaluated for genetic correlation with schizophrenia. Three 
genetically homogeneous and distinct schizotypy factors were identified that were especially 
sensitive to genetic effects on underreporting pathology and perhaps interpersonal deficits among 
non-psychotic relatives of schizophrenia probands, but not among relatives of MDD or substance 
dependence probands. Although their direction was unexpected, these genetic factors may have 
the potential to be particularly useful endophenotypes in genetic linkage analyses of 
schizophrenia.  
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Table 1. DSM-IV-TR Diagnostic Criteria for Schizotypal Personality Disorder (301.22) 
 
A. 
 
A pervasive pattern of social and interpersonal deficits marked by acute discomfort with, and 
reduced capacity for, close relationships as well as by cognitive or perceptual distortions and 
eccentricities of behavior, beginning by early adulthood and present in a variety of contexts, as 
indicated by five (or more) of the following: 
 
  
1) Ideas of reference (excluding delusions of reference). 
  
2) Odd beliefs or magical thinking that influences behavior and is inconsistent with subcultural 
norms (e.g., superstitiousness, belief in clairvoyance, telepathy, or “sixth sense”; in children 
and adolescents, bizarre fantasies or preoccupations). 
  
3) Unusual perceptual experiences including bodily illusions. 
  
4) Odd thinking and speech (e.g., vague, circumstantial, metaphorical, overelaborate, or 
stereotyped). 
  
5) Suspiciousness or paranoid ideation. 
  
6) Inappropriate or constricted affect. 
  
7) Behavior or appearance that is odd, eccentric, or peculiar. 
  
8) Lack of close friends or confidants other than first-degree relatives. 
  
9) Excessive social anxiety that does not diminish with familiarity and tends to be associated 
with paranoid fears rather than negative judgments about self. 
  
 B. Does not occur exclusively during the course of schizophrenia, a mood disorder with psychotic 
features, another psychotic disorder, or a pervasive developmental disorder. 
 
83 
Table 2. Social-Interpersonal SPD Symptoms in Relatives 
 
 
Study Characteristics of the Relatives of Schizophrenia 
Probands 
Schizotypy Assessment Comparison with Psychiatrically Healthy Controls** Comparison with Relatives of Non-Schizophrenia Probands 
                 
 Relations
hip 
Se
x 
Age Ethnicit
y 
Psychiatric  Measure  Factor screening match to effect  proban
d  
screening  match to effect  
 to 
Proband 
(n) 
% 
ma
le 
mean 
(SD) 
% 
Caucasi
an 
Status (instrument 
type) 
   Symptom criteria (n) schiz 
relatives 
size p value diagnos
is 
criteria (n) schiz 
relatives 
size p value 
                 
Grove et al, 
1991 
parents, 
sibs,  
46.
0% 
35 n/a unscreened SSP Social-Interpersonal 
Factor 
no diagnosis (18) n/a d1 = 
1.65 
p = 0.0001     
 half-sibs (61)    (interview)          
                 
Torgersen et al, 
1993 
non-twin, 
1st  
41.
8% 
53.6 
(13.7) 
n/a no schiz SCID-II    Social Anxiety     major  non-twin, 1st  age, sex    d5 = 
0.32 
   p = 0.02 
 degree relatives   (interview)    Social Isolation     depress
ion 
degree relatives;     n/a    n.s 
 (134)*         Inapropriate Affect     no schiz (65)    d5 = 
0.30 
   p = 0.04 
          Suspiciousness           n/a    n.s 
                 
Lyons et al, 
1994 
parents, 
sibs, 
50.
0% 
49.2 n/a > 3 
symptoms  
SIDP 
(interview) 
   Social Anxiety     affectiv
e d/o 
parents, sibs, age, sex,     n/a    n.s 
 offspring (34)   of SPD SANS, 
SAPS 
   Social Isolation      offspring; educatio
n 
   n/a    n.s 
      (clinician 
ratings) 
   Inadequate rapport     > 3 symptoms of     n/a    p < 0.05 
          Suspiciousness      SPD (14)     n/a    n.s 
                 
Kendler et al, 
1995 
1st degree n/a n/a n/a no schiz SIS Negative Schizotypy 
Factor 
1st degree 
relatives of   
n/a d3 = 
0.62 
p = 0.0001 affectiv
e d/o 
1st degree 
relatives; 
n/a d3 = 
0.34 
p = 0.02 
(Roscommon  relatives (314)  or 
schizoaff 
(interview)    Poor Rapport unscreened control    no schiz or    
Family Study)         Aloofness/Coldness probands; no schiz     schizoaff (183)   
          Guardedness or schizoaff (575)        
          Odd behavior          
       Avoident Symptoms Factor  d3 = 
0.27 
p = 0.003   d3 = 
0.35 
p = 0.001 
          Social Isolotion          
          Social Anxiety          
          Hypersensitivity          
          Apparent Anxiety         
       Social Dysfunction Factor  d3 = 
0.67 
p = 0.0008   n/a  
          Low Motivation          
          Low Occupational Functioning        
       Suspiscious Behavior Factor  d3 = 
0.50 
p = 0.004   d3 = 
0.87 
p = 0.02 
          Hypervigilance          
          Irritability          
                 
Squires-Wheeler  offspring 
(48) 
n/a 24.3 
(1.9) 
100.0% unscreened PDE Negative Schizotypy 
Factor 
unscreened 
offspring of 
age, 
ethnicity 
d2 = 
1.10 
p < 0.01 affectiv
e d/o 
unscreened  age, 
ethnicity 
d2 = 
0.41 
n.s. 
  et al, 1997      (interview)    No Close Friends no diagnosis parents (84)   offspring (40)   
(New York High         Constricted/Inappropriate Affect        
Risk Study)          Poverty of Speech           
          Poverty of Emotion         
          Indifference          
          Odd Behavior/Appearance         
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Table 2. Social-Interpersonal SPD Symptoms in Relatives (cont.)
Kremen et al, 
1998 
1st degree 22.
5% 
m: 40.8 
(13.9) 
m: 
88.9% 
no 
psychosis 
or 
SPQ  Social-Interpersonal 
Factor 
no 
psychopathology 
on 
age, sex, d5 = 
0.41 
n.s. (p < 0.07)‡     
 relatives (40) f: 42.9 
(11.6) 
f: 
77.4% 
substance 
abuse  
(questionnaire) the MMPI-168 (< 
70) (44) 
ethnicity    m: 
n/a 
   n.s.      
             f: 
n/a 
   n.s.      
                 
Yaralian et al, 
2000 
relatives 
(13) 
92.
3% 
29.9 
(7.3) 
76.9% unscreened SPQ  Social-Interpersonal 
Factor 
no family history 
of 
age, sex,  d2 = 
0.08  
n.s. alcohol
/drug  
unscreened age, sex, d2 = 
0.01  
n.s 
      (questionn
aire) 
   Social Anxiety schiz-spectrum ethnicity    n/a    n.s. abuse relatives (38) ethnicity    n/a    n.s 
          No Close Friends or alcohol/drug    n/a    n.s.       n/a    n.s 
          Constricted Affect abuse (51)     n/a    n.s.       n/a    n.s 
          Paranoid Ideation†     d4 = 
0.75 
   p = 0.021      d4 = 
0.60 
   n.s. (p = 
0.06) 
                 
Appels et al, 
2004 
parents  50.
0% 
median: 
54.9 
n/a no 
psychosis 
or 
SPQ Negative Schizotypy 
Factor 
no psychotic, 
affective, 
age, sex,  n/a n.s.      
 (36 couples)   substance 
abuse 
(questionn
aire) 
   Social Anxiety substance, or 
personality 
handedness,       
          No Close Friends diagnoses (26 
couples) 
education, IQ       
          Constricted Affect         
          Suspiciousness†          
                 
Calkins et al, 
2004 
parents, 
sibs,  
49.
2% 
46.5 
(15.3) 
n/a no 
psychosis 
SPQ Social-Interpersonal 
Factor 
no diagnosis (109) sex d1 = 
0.55 
p < 0.001     
 offspring (124)   (questionn
aire) 
   Social Anxiety      d1 = 
0.53 
   p < 0.001     
          No Close Friends     d1 = 
0.52 
   p < 0.001     
          Constricted Affect     d1 = 
0.36 
   p < 0.01     
          Suspiciousness†     n/a    n.s.      
                 
Schurhoff et al, 
2005 
parents, 
sibs,  
44.
7% 
53.9 
(15.2) 
n/a no schiz SPQ  Negative Schizotypy Factor    bipolar 
d/o 
parents, sibs, age, sex d2 = 
0.00 
n.s 
 offspring (85)   or bipolar (questionnaire)      offspring;    
             no schiz or    
             bipolar (95)    
                 
Mean Effect Size for Factor-Level Comparisons6     d = 0.59    d = 0.37 (affective 
disorders) 
                 
PDE - Personality Disorder Examination unscreened - psychiatric diagnoses not excluded  1 - Glass' d (relative M - control M / control SD) n/a - not reported, not able to calculate 
SANS - Scale for the Assessment of Negative Symptoms  no diagnosis - all psychiatric diagnoses excluded  2 - Glass' d calculated by current author  n.s. - not significant (p > 0.05) 
SAPS - Scale for the Assessment of Positive Symptoms  schiz - schizophrenia  3 - Cohen's d (relative M - control M / pooled SD) transformed from  † - On the SPQ, suspiciousness/paranoid ideation 
loads on both  
SCID-II - Structured Clinical Interview for DSM-III-R 
Personality Disorders 
schizaff - schizoaffective disorder           odds ratio: d = lno(√3/π) (Hasselblad & Hedges,1995)         the social-interpersonal and cognitive-
perceptual factors 
SIDP - Structured Interview for DSM-III Personality Disorders MMPI - Minnesota Multiphasic Personality Inventory 4 - Cohen's d transformed from t: d = t(n1+n2)/√df(√n1n2);  ‡ - trend of significant group-by-sex interaction (p < 
0.06) 
SIS - Structured Interview for Schizotypy SPD - Schizotypal personality disorder           [pooled, equal variences assumed] (Rosenthal, 1994) empty cells: comparisons not reported 
SPQ - Schizotypal Personality Questionaire m - male   5 - Cohen's d transformed from chi square: rφ = √Χ²/n; d = 2r/√1-r²   
SSP - Schedule for Schizotypal Personalities f - female             (Johnson and Eagly, 2000)      
        6 - Mean effect sizes were calculated for factor comparisons by weighting each ‘d’  
* Torgersen et al, 1993 also reported results for MZ and DZ twins - all comparisons were not significant.           by the inverse of the conditional variance of ‘d’ (Shadish & Haddock, 1994) 
   As the results were uniformly not significant, they were not listed in this table in order to conserve space       
                 
** Unless otherwise noted, healthy control groups are comprised of individual control probands        
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Table 3. Cognitive-Perceptual SPD Symptoms in Relatives 
 
Study Characteristics of the Relatives of Schizophrenia 
Probands 
Schizotypy Assessment Comparison with Psychiatrically Healthy Controls** Comparison with Relatives of Non-Schizophrenia Probands 
                 
 Relations
hip 
Se
x 
Age Ethnicit
y 
Psychiatri
c  
Measure  Factor screening match to effect  proban
d  
screening  match to effect  
 to 
Proband 
(n) 
% 
ma
le 
mean 
(SD) 
% 
Caucasi
an 
Status (instrumen
t type) 
   Symptom criteria (n) schiz 
relatives 
size p value diagno
sis 
criteria (n) schiz 
relatives 
size p value 
                 
Grove et al, 
1991 
parents, 
sibs,  
46.
0% 
35 n/a unscreene
d 
SSP  Cognitive-Perceptual 
Factor 
no diagnosis (18) n/a d1 = 
0.51 
n.s. (p = 0.056)     
 half-sibs (61)    (interview)          
                 
Torgersen et al, 
1993 
non-twin, 
1st   
41.
8% 
53.6 
(13.7) 
n/a no 
psychosis 
SCID-II    Illusions     major  non-twin, 1st  age, sex    n/a    n.s. 
 degree relatives    (interview
) 
   Ideas of Reference    depress
ion 
degree relatives;     n/a    n.s. 
 (134)*         Magical Thinking     no schiz (65)    n/a    n.s. 
                 
Lyons et al, 
1994 
parents, 
sibs, 
50.
0% 
49.2 n/a > 3 
Symptoms  
SIDP 
(interview
) 
   Illusions     affecti
ve d/o 
parents, sibs,  age, sex,     n/a    n.s 
 offspring (34)   of SPD SANS, 
SAPS 
   Ideas of reference     offspring; education    n/a    n.s 
      (clinician 
ratings) 
   Magical ideation      > 3 symptoms of     n/a    n.s 
             SPD (14)    
                 
Kendler et al, 
1995 
1st degree n/a n/a n/a no schiz SIS Positive Schizotypy 
Factor 
1st degree 
relatives of   
n/a d3 = 
0.36 
p = 0.005 affecti
ve d/o 
1st degree 
relatives; 
n/a n/a n.s 
(Roscommon  relatives (314)  or 
schizoaff 
(interview
) 
   Illusions unscreened control    no schiz or   
Family Study)         Ideas of reference probands; no schiz     schizoaff (183)   
          Suspiciousness or schizoaff (575)        
          Depersonalization         
          Recurrent suicidal threats         
                 
Squires-
Wheeler  
offspring 
(48) 
n/a 24.3 
(1.9) 
100.0% unscreene
d 
PDE Positive Schizotypy 
Factor 
unscreened 
offspring of 
age, 
ethnicity 
d2 = 
0.25 
p < 0.05 affecti
ve d/o 
unscreened  age, 
ethnicity 
d2 = -
0.08 
n.s. 
  et al, 1997      (interview
) 
   Unusual perceptual 
experiences 
no diagnosis parents (84)   offspring (40)   
(New York High         Odd beliefs/magical thinking         
Risk Study)          Ideas of reference           
          Suspiciousness          
          Circumstantial/tangential speech        
                 
Kremen et al, 
1998 
1st degree 22.
5% 
m: 40.8 
(13.9) 
m: 
88.9% 
no 
psychosis 
or 
SPQ  Cognitive-Perceptual 
Factor 
no 
psychopathology 
on 
age, sex, d5 = 
0.65 
p < 0.004‡     
 relatives (40) f: 42.9 
(11.6) 
f: 
77.4% 
substance 
abuse 
(questionnaire) the MMPI-168 (< 
70) (44) 
ethnicity    m: 
n/a 
   p < 0.006     
             f: 
n/a 
   n.s      
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Table 3. Cognitive-Perceptual SPD Symptoms in Relatives (cont.)
Yaralian et al, 
2000 
relatives 
(13) 
92.
3% 
29.9 
(7.3) 
76.9% unscreene
d 
SPQ Cognitive-Perceptual 
Factor 
no family history 
of 
age, sex, d2 = 
1.02 
p < 0.003 alcohol
/drug  
unscreened  age, sex, d2 = 
0.79 
p < 0.012 
      (questionn
aire) 
   Unusual 
Percep.Experiences 
schiz-spectrum ethnicity    d4 = 
0.87 
   p < 0.01 abuse relatives (38) ethnicity    d4 = 
0.94 
   n.s. 
          Ideas of Reference or alcohol/drug    d4 = 
0.87 
   p = 0.01      d4 = 
0.49 
   n.s 
          Magical Thinking abuse (51)     n/a    n.s.       n/a    n.s 
          Paranoid Ideation†     d4 = 
0.75 
   p = 0.021      d4 = 
0.60 
   n.s. (p = 
0.06) 
                 
Appels et al, 
2004 
parents  50.
0% 
median: 
54.9 
n/a no 
psychosis 
or 
SPQ Positive Schizotypy 
Factor 
no psychotic, 
affective, 
age, sex,   n/a (-)  p = 0.027      
 (36 couples)   substance 
abuse 
(questionn
aire) 
   Unusual 
Percep.Experiences 
substance, or 
personality 
handedn
ess, 
   n/a 
(-)  
   n.s. (p = 0.053)    
          Ideas of Reference diagnoses (26 
couples) 
educatio
n, IQ 
   n/a 
(-)  
   n.s.      
          Magical Thinking     n/a 
(-)  
   p = 0.016     
          Suspiciousness†     n/a 
(-)  
   n.s.      
                 
Calkins et al, 
2004 
parents, 
sibs,  
49.
2% 
46.5 
(15.3) 
n/a no 
psychosis 
SPQ Cognitive-Perceptual 
Factor 
no diagnosis 
(109) 
sex d1 = 
0.24 
n.s. (p = 0.08)     
 offspring (124)   (questionn
aire) 
   Unusual Percep.Experiences     d1 = 
0.38 
   p < 0.05     
          Ideas of Reference     n/a    n.s.      
          Magical Thinking     n/a    n.s.      
          Suspiciousness†     n/a    n.s.      
                 
Schurhoff et al, 
2005 
parents, 
sibs,  
44.
7% 
53.9 
(15.2) 
n/a no schiz SPQ Positive Schizotypy Factor    bipolar 
d/o 
parents, sibs,  age, sex d2 = 
0.10 
n.s 
 offspring (85)   or bipolar (questionnaire)      offspring;    
             no schiz or    
             bipolar (95)   
                 
Mean Effect Size for Factor-Level Comparisons6     d = 0.37    d = 0.04 (affective 
disorders) 
                 
PDE - Personality Disorder Examination unscreened - psychiatric diagnoses not excluded  1 - Glass' d (relative M - control M / control SD) n/a - not reported, not able to calculate 
SANS - Scale for the Assessment of Negative Symptoms  no diagnosis - all psychiatric diagnoses excluded  2 - Glass' d calculated by current author  n.s. - not significant (p > 0.05) 
SAPS - Scale for the Assessment of Positive Symptoms  schiz - schizophrenia  3 - Cohen's d (relative M - control M / pooled SD) transformed from  † - On the SPQ, suspiciousness/paranoid ideation 
loads on both  
SCID-II - Structured Clinical Interview for DSM-III-R 
Personality Disorders 
schizaff - schizoaffective disorder           odds ratio: d = lno(√3/π) (Hasselblad & Hedges,1995)         the social-interpersonal and cognitive-
perceptual factors 
SIDP - Structured Interview for DSM-III Personality 
Disorders 
MMPI - Minnesota Multiphasic Personality Inventory 4 - Cohen's d transformed from t: d = t(n1+n2)/√df(√n1n2);  ‡ - significant group-by-sex interaction (males > 
females, p < 0.007) 
SIS - Structured Interview for Schizotypy SPD - Schizotypal personality disorder           [pooled, equal variences assumed] (Rosenthal, 1994) (-) - effect is negative (relatives < controls) 
SPQ - Schizotypal Personality Questionaire m - male   5 - Cohen's d transformed from chi square: rφ = √Χ²/n; d = 2r/√1-r²  empty cells: comparisons not reported 
SSP - Schedule for Schizotypal Personalities f - female            (Johnson and Eagly, 2000)      
        6 - Mean effect sizes were calculated for factor comparisons by weighting each ‘d’  
* Torgersen et al, 1993 also reported results for MZ and DZ twins - all comparisons were not significant.           by the inverse of the conditional variance of ‘d’ (Shadish & Haddock, 1994) 
   As the results were uniformly not significant, they were not listed in this table in order to conserve space      
                 
** Unless otherwise noted, healthy control groups are comprised of individual control probands        
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Table 4. Disorganized SPD Symptoms in Relatives 
Study Characteristics of the Relatives of Schizophrenia Probands Schizotypy Assessment Comparison with Psychiatrically Healthy Controls** Comparison with Relatives of Non-Schizophrenia Probands 
                 
 Relationship Sex Age Ethnicity Psychiatric  Measure  Factor screening match to effect  proband  screening  match to effect  
 to Proband 
(n) 
% 
male 
mean (SD) % 
Caucasia
n 
Status (instrument 
type) 
   Symptom criteria (n) schiz 
relatives 
size p value diagnosis criteria (n) schiz 
relatives 
size p value 
                 
Torgersen et al, 
1993 
non-twin, 
1st   
41.8
% 
53.6 (13.7) n/a no psychosis SCID-II    Odd speech    major  non-twin, 1st  age, sex    d5 = 
0.30 
   p = 
0.03 
 degree relatives    (interview)      depressio
n 
degree relatives;    
 (134)*            no schiz (65)   
                 
Lyons et al, 1994 parents, 
sibs, 
50.0
% 
49.2 n/a > 3 
Symptoms  
SIDP 
(interview) 
   Odd speech    affective 
d/o 
parents, sibs,  age, sex,     n/a    n.s. 
 offspring (34)   of SPD SANS, SAPS      offspring; education  
      (clinician ratings)      > 3 symptoms of    
             SPD (14)    
                 
Kendler et al, 1995 1st degree n/a n/a n/a no schiz SIS Odd Speech 
Factor  
1st degree relatives of   n/a d3 = 
0.96 
p = 
0.003 
affective 
d/o 
1st degree 
relatives; 
n/a n/a n.s 
(Roscommon  relatives (314)   or schizoaff (interview)    Cognitive 
slippage 
unscreened control    no schiz or    
Family Study)         Odd speech probands; no schiz     schizoaff (183)   
        or schizoaff (575)        
                 
Kremen et al, 1998 1st degree 22.5
% 
m: 40.8 
(13.9) 
m: 88.9% no psychosis 
or 
SPQ Disorganized 
Factor 
no psychopathology 
on 
age, sex, d5 = 
0.22 
n.s.       
 relatives (40) f: 42.9 
(11.6) 
f: 77.4% substance 
abuse 
(questionnaire) the MMPI-168 (< 70) 
(44) 
ethnicity        
                 
Yaralian et al, 2000 relatives 
(13) 
92.3
% 
29.9 (7.3) 76.9% unscreened SPQ Disorganized 
Factor 
no family history of age, sex, d2 = 
0.49  
n.s. alcohol/d
rug  
unscreened age, sex, d2 = 
0.25  
n.s 
      (questionnair
e) 
   Odd behaviors schiz-spectrum ethnicity    n/a    n.s. abuse relatives (38) ethnicity    n/a    n.s 
          Odd speech or alcohol/drug     n/a    n.s.       n/a    n.s 
        abuse (51)         
                 
Appels et al, 2004 parents  50.0
% 
median: 
54.9 
n/a no psychosis 
or 
SPQ Disorganized 
Factor 
no psychotic, 
affective, 
age, sex,  n/a n.s.      
 (36 couples)   substance 
abuse 
(questionnair
e) 
   Odd Behaviors substance, or 
personality 
handedness,       
          Odd Speech diagnoses (26 
couples) 
education, IQ       
                 
Calkins et al, 2004 parents, 
sibs,  
49.2
% 
46.5 (15.3) n/a no psychosis SPQ Disorganized 
Factor 
no diagnosis (109) sex d1 = 
0.17 
n.s.      
 offspring (124)    (questionnair
e) 
   Odd Behaviors     d1 = 
0.11 
   n.s.      
          Odd Speech     d1 = 
0.17 
   n.s.      
                 
Schurhoff et al, 
2005 
parents, 
sibs,  
44.7
% 
53.9 (15.2) n/a no schiz SPQ  Disorganized Factor    bipolar 
d/o 
parents, sibs,  age, sex d2 = - 
0.16 
n.s 
 offspring (85)   or bipolar (questionnaire)      offspring;    
             no schiz or     
             bipolar (95)    
                 
Mean Effect Size for Factor-Level Comparisons6     d = 0.73      
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Table 4. Disorganized SPD Symptoms in Relatives (cont.)
SANS - Scale for the Assessment of Negative Symptoms  unscreened - psychiatric diagnoses not excluded  1 - Glass' d (relative M - control M / control SD) n/a - not reported, not able to calculate 
SAPS - Scale for the Assessment of Positive Symptoms  no diagnosis - all psychiatric diagnoses excluded  2 - Glass' d calculated by current author  n.s. - not significant (p > 0.05) 
SCID-II - Structured Clinical Interview for DSM-III-R Personality 
Disorders  
schiz - schizophrenia  3 - Cohen's d (relative M - control M / pooled SD) transformed from  empty cells: comparisons not reported  
SIDP - Structured Interview for DSM-III Personality Disorders schizaff - schizoaffective disorder           odds ratio: d = lno(√3/π) (Hasselblad & Hedges,1995)   
SIS - Structured Interview for Schizotypy MMPI - Minnesota Multiphasic Personality Inventory 5 - Cohen's d transformed from chi square: rφ = √Χ²/n; d = 2r/√1-r²    
SPQ - Schizotypal Personality Questionaire SPD - Schizotypal personality disorder           (Johnson and Eagly, 2000)      
SSP - Schedule for Schizotypal Personalities m - male   6 - Mean effect size was calculated for factor comparisons by weighting each ‘d’  
     f - female             by the inverse of the conditional variance of ‘d’ (Shadish & Haddock, 1994) 
                 
* Torgersen et al, 1993 also reported results for MZ and DZ twins - all comparisons were not significant.        
   As the results were uniformly not significant, they were not listed in this table in order to conserve space       
                 
** Unless otherwise noted, healthy control groups are comprised of individual control probands         
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Table 5. DSM-IV-TR Criteria for Schizotypal Personality Disorder and Corresponding SIS Scales 
DSM-IV-TR Criterion SIS Scale Characteristics associated with high scale ratings 
Lack of close friends  or confidants Social Isolation Few friends; little contact with others, including friends and relatives; lacks desire for more contact 
 
Introversion Prefers/desires being alone; quiet and reserved around others 
 
Social/Interpersonal Functioning Lacks meaningful friendships;  absence of social interactions/activities 
 
Sexual Anhedonia Absence of sexual relationships; low drive for sexual relations 
   Excessive social anxiety associated with  
paranoid fears Sensitivity Hypersensitive to criticism;  easily upset 
 
Social Anxiety Worries about what people think of them; worries about appearing foolish 
   Inappropriate or  constricted affect Restricted Emotion Lacks strong feelings, convictions, and/or emotional reactivity; low desire to express feelings/affection 
 
Affect Flat, inappropriate, and/or labile affect, appears cold towards interviewer 
 
Rapport Poor eye contact; body language suggests detachment from interviewer; absence of emotional rapport 
   Suspiciousness or  paranoid ideation Anger to Perceived Slights Easily insulted; perceives criticism when none was intended; quick to react with anger 
 
Suspiciousness 
Believes people are untrustworthy; holds grudges; believes they were, or will be taken advantage 
of/victimized 
  Pathological Jealousy  Easily and frequently feels jealous without justification; suspicious about partners’ fidelity 
 
Irritability Irritable or argumentative towards interviewer and/or others with whom they have contact  
 
Guardedness Appeared hypervigilant; made suspicious comments; perceived hidden meaning in the interview questions 
   Ideas of reference Ideas of Reference: Being Watched Sense of being watched or scrutinized in public; singled out for special attention 
 
Ideas of Reference: Remarks Sense of being talked about and/or laughed at in public 
   
Odd beliefs or magical thinking Magical Thinking 
Can read others’ minds or others are reading their mind; can foretell or affect the future; sense the presence 
of and/or feel influenced by unseen forces or spirits; highly superstitious 
 
Psychotic-like Phenomena 
Thoughts/feelings come into their mind which do not belong; thoughts are being put into or taken out of their 
head by an outside agency or power; their thoughts can be heard by others 
   
Unusual perceptual experiences Illusions 
Mistakes objects for people or animals; hears whispering, their name called, or other sounds; senses the 
presence of an unseen person or force 
   
Odd thinking and speech  Organization of Speech/Thought 
Speech during interview is frequently digressive, tangential, or circumstantial; presence of derailment and 
loose associations; rate of speech is pressured or unusually slow. 
   Behavior or appearance that is odd, 
eccentric, or peculiar Odd/Eccentric Behavior 
Presence of odd movements, tics, posture, or gait; socially inappropriate toward interviewer (either overly 
familiar or hostile); talking and/or laughing to themselves; expresses inappropriate humor 
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Table 6. Number of Individuals with DIGS per Family 
 
Individuals with DIGS  
per family, n 
Frequency of family size in  
DIGS sample, n 
 2  2 
 3  3 
 4  1 
 5  1 
 6  2 
 7  4 
 8  4 
 9  1 
 10  2 
 11  2 
 12  1 
 13  3 
 14  1 
 15  2 
 16  3 
 17  1 
 20  1 
 23  1 
 24  2 
 29  1 
 32  1 
 34  1 
 36  1 
 42  1 
 70  1 
Mean family size = 14.86   
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Table 7. Number of Affected (Schizophrenia/Schizoaffective Disorder, Depressed) Individuals per Family 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Affected individuals per family, n  
Frequency of families in DIGS 
sample, n 
 1  4 
 2  27 
 3  7 
 4  2 
 5  2 
 6  1 
Mean per family = 2.4  
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Table 8. Demographics of Proband, Relative, and Control Participants with DIGS Data 
 
 
1 One proband was diagnosed as schizoaffective, depressed type in the context of a previous study and was not administered the 
DIGS. 
 
 
Participant Group Total, n 
Age, yrs:   
mean (sd), range  
Sex:  
% male 
Education, yrs: 
mean (sd) 
Site:  
% Pitt 
Proband 421 46.4 (13.1), 20-82  58.1 12.3 (2.2) 41.9 
Biological Relative 597 45.2 (17.7), 15-87  47.2 13.2 (3.0) 42.7 
 1st  Degree Total 150 49.8 (15.9), 16-87  46.7 13.0 (3.0) 46.0 
  Parents 39 66.2 (11.7), 40-87  35.9 12.4 (3.3) 48.7 
  Siblings 96 47.0 (11.1), 21-84  50.0 13.2 (3.1) 43.8 
  Children 15 25.8 (8.5), 16-47  53.3 12.8 (2.5) 53.3 
 2nd Degree  Total 129 46.2 (21.3), 15-87  51.2 12.8 (3.2) 43.4 
  Grandparents 5 72.4 (4.4), 69-80  60.0 10.8 (4.6) 80.0 
  Uncles/Aunts 55 65.5 (11.8), 41-87  52.7 12.4 (3.1) 41.8 
  Half-Siblings 4 29.0 (5.5), 21-33  75.0 10.8 (1.5) 50.0 
 
 
 
Nephews/ 
Nieces 65 29.0 (10.0), 15-56  47.7 13.5 (3.1) 41.5 
 3rd Degree 1st Cousins 124 44.5 (13.5), 15-77  51.6 13.8 (2.8) 54.8 
 4th Degree  2nd Cousins  145 36.4 (16.3), 15-82 42.8 13.0 (2.8) 42.1 
Non-Biological  Relative 49 55.7 (13.4), 26-79 40.8 14.0 (2.8) 2.0 
Controls 88 51.9 (17.5), 19-84  40.9 15.2 (2.4) 100.0 
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Table 9. Clinical Characteristics by Group 
 
 
Diagnosis1, n Participant Group 
 
 
Proband Relatives’ Degree of Relatedness Control 
  
 
All First Second Third Fourth  Non-bio   
   Total Parent Sibling Child Total 
 
Grand- 
parent 
Uncle/ 
Aunt 
Half-
sibling 
Nephew/ 
Niece 
First 
cousin 
Second 
cousin  
Step-rels, 
Spouses  
 
Total 43 597 150 39 96 15 129 5 55 4 65 124 145 49 88 
 
Schiz/schizaff-
dep 
 43 60 49 8 40 1 4 0 1 0 3 2 4 1 0 
 
Schiz 
 41 51 42 6 35 1 4 0 1 0 3 2 3 0 0 
 
Schizaff-d 
 2 9 7 2 5 0 0 0 0 0 0 0 1 1 0 
Schizaff-bp 
 0 4 2 0 2 0 1 0 1 0 0 1 0 0 0 
Bipolar 
 0 8 1 0 1 0 3 1 1 0 1 2 1 1 0 
Other 
psychosis 
 0 16 7 1 6 0 3 0 2 0 1 2 3 1 0 
Cluster A pd 
 0 25 3 1 2 0 10 1 5 0 4 2 9 1 0 
 
Schizotypal 
 0 19 2 0 2 0 6 0 4 0 2 2 8 1 0 
 
Paranoid 
 0 3 1 1 0 0 2 1 1 0 0 0 0 0 0 
 
Schizoid 
 0 3 0 0 0 0 2 0 0 0 2 0 1 0 0 
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Table 9: Clinical Composition (cont.) 
 
1 Diagnoses of schizophrenia, schizoaffective disorder-depressed type, schizoaffective disorder-bipolar type, bipolar disorder, and other psychotic disorders are hierarchical as 
presented. Diagnoses of cluster A personality disorders, major depressive disorder (MDD), other mood disorders, substance disorders, and dementia are non-hierarchical and 
not exclusive except where noted. 
 
 
Diagnosis1, n Participant Group 
 
 
Proband Relatives’ Degree of Relatedness Control 
  
 
All First Second Third Fourth Non-bio   
   Total Parent Sibling Child Total 
 
Grand- 
parent 
Uncle/ 
Aunt 
Half-
sibling 
Nephew/ 
Niece 
First 
cousin 
Second 
cousin 
Step-rels, 
Spouses  
 
Total 43 597 150 39 96 15 129 5 55 4 65 124 145 49 88 
Total MDD 
 0 120 22 8 13 1 27 1 6 1 19 25 33 13 24 
 
No 
psychosis or 
Cluster A 0 110 22 8 13 1 22 1 3 1 17 25 31 10 24 
 
 
With 
psychosis or 
Cluster A 0 10 0 0 0 0 5 0 3 0 2 0 2 3 0 
 
Other mood 2 59 15 3 11 1 8 0 2 0 6 13 22 1 4 
 
Substance d/o 11 153 42 7 32 3 29 1 12 2 14 28 45 9 16 
 
Dementia 0 2 1 0 1 0  0 1 0 0 0 0 0 0 
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Table 10. Characteristics of Pedigree and Control Participants for whom SIS Data were Available 
 
1 Diagnoses of Cluster A personality disorders, Major depressive disorder (MDD), Other mood disorders, and Substance disorders are non-hierarchical and not exclusive. 
2 Non-biological relatives include step-relatives and spouses. 
  Demographics Diagnosis, n1 
 
Group Total, n 
 
Age, yrs:  mean (sd), 
range  
Sex: % 
male 
Education, yrs: 
mean (sd) Cluster A MDD 
Other 
mood 
Substance 
Dep. 
No 
diagnosis 
 
Relatives 480 44.6 (17.8), 15-85  46.0 13.3 (2.9) 24 103 41 102 258 
 
 
1st  Degree Total 84 49.8 (17.6), 16-82  41.7 13.4 (3.0) 3 19 7 18 48 
  
 
Parents 26 67.1 (10.2), 49-82  42.3 12.7 (3.1) 1 7 0 5 17 
  
 
Siblings 44 47.8 (11.2), 21-75  38.6 14.0 (3.1) 2 11 6 10 22 
  
 
Children 14 24.3 (6.4), 16-39  50.0 12.9 (2.5) 0 1 1 3 9 
 
 
2nd Degree  Total 110 45.5 (21.0), 15-85 51.8 13.0 (3.2) 10 20 5 17 65 
  
 
Grand-parents 4 70.5 (1.3), 69-72 50.0 12.5 (2.9) 1 1 0 0 2 
  
 
Uncles/Aunts 46 64.9 (11.9), 41-85  54.3 12.6 (3.1) 5 3 1 8 30 
  
 
Half-Siblings 4 29.0 (5.5), 21-33  75.0 10.8 (1.5) 0 1 0 2 1 
 
 
 
 
Nephew/Nieces 56 28.9 (9.4), 15-51  48.2 13.5 (3.2) 4 15 4 7 32 
 
 
3rd Degree 1st Cousins 110 44.9 (13.8), 15-77  51.8 13.7 (2.6) 2 24 11 23 61 
 
 
4th Degree  2nd Cousins  132 36.3 (16.0), 15-78 40.9 13.0 (2.8) 9 30 17 38 56 
 
 
Non-Bio Relative2 44 56.1 (13.3), 26-79 40.9 14.0 (2.9) 1 10 1 6 28 
 
Controls 88 51.9 (17.5), 19-84  40.9 15.2 (2.4) 0 24 4 16 51 
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Table 11. Excluded and Included Relative and Control Cases and Missing Data for Each SIS Scale 
 
   Relatives Controls 
Mean Group 
Difference 
Scale 
Items, 
n Alpha 
Cases, 
n 
Mean 
(sd) Skewness1 
Cases, 
n 
Mean 
(sd) Skewness2 F p-value 
Social Isolation 10 0.8 478 
1.50 
(0.98) 1.7 88 
1.01 
(0.62) 2.1 20.7 <.001 
Introversion 17 0.9 480 
1.53 
(1.30) 0.7 88 
1.32 
(1.22) 0.7 2.0 .153 
Sexual Anhedonia 4 0.8 365 
1.02 
(1.31) 2.1 53 
0.95 
(1.11) 2.2 0.1 .709 
Social/Interpersonal 
Functioning 1 n/a 443 
0.69 
(0.89) 1.2 88 
0.31 
(0.55) 2.1 14.9 <.001 
Sensitivity 8 0.9 479 
2.08 
(1.38) 0.4 88 
1.85 
(1.24) 0.3 2.1 .147 
Social Anxiety 7 0.8 479 
1.27 
(0.98) 1.1 88 
0.92 
(0.82) 1.2 10.1 .002 
Restricted Emotion 9 0.7 479 
1.44 
(0.75) 0.7 88 
1.32 
(0.66) 0.8 2.0 .158 
Affect 5 0.8 447 
0.34 
(0.46) 1.6 87 
0.18 
(0.30) 1.9 10.1 .002 
Rapport 4 0.9 446 
0.35 
(0.62) 2.2 87 
0.19 
(0.42) 3.0 5.0 .026 
Anger to Perceived 
Slights 
8 
 0.8 479 
1.16 
(1.35) 1.2 88 
0.69 
(1.05) 1.7 9.6 .002 
Suspiciousness 20 0.9 479 
1.07 
(0.95) 1.4 88 
0.69 
(0.76) 1.5 12.1 .001 
Guardedness 3 0.9 447 
0.17 
(0.46) 3.2 88 
0.04 
(0.17) 4.2 7.1 .008 
Irritability 1 n/a 447 
0.11 
(0.38) 3.5 88 
0.13 
(0.42) 3.5 0.1 .810 
Pathological 
Jealousy 6 0.8 479 
0.79 
(1.26) 1.7 88 
0.35 
(0.78) 2.6 10.0 .002 
Ideas of Reference: 
Being Watched 10 0.9 478 
0.69 
(1.15) 2.0 88 
0.42 
(0.84) 2.5 4.5 .035 
Ideas of Reference: 
Remarks 10 0.9 479 
0.61 
(0.98) 1.8 88 
0.33 
(0.64) 1.9 6.8 .009 
Magical Thinking 23 0.9 479 
0.45 
(0.67) 2.6 88 
0.38 
(0.42) 1.0 0.9 .335 
Psychotic-like 
Phenomena 10 0.7 478 
0.55 
(0.51) 1.7 88 
0.43 
(0.45) 2.0 3.9 .049 
Illusions 8 0.8 478 
0.66 
(0.76) 2.1 88 
0.53 
(0.62) 1.8 2.4 .120 
Organization of 
Speech/ Thought 6 0.8 447 
0.20 
(0.43) 2.5 88 
0.06 
(0.22) 5.3 8.2 .004 
Odd/ Eccentric 
Behavior 4 0.8 447 
0.12 
(0.33) 3.7 88 
0.03 
(0.14) 4.3 5.8 .016 
 
 
 
 
Included Cases, n 
 
Total Percent of items missing 
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Table 12. SIS Scale Descriptive Characteristics and Mean Relative and Control Group Differences 
 
 
Alpha: Cronbach’s Alpha calculated on the total combined sample (relatives and controls) 
n/a: Not applicable; Cronbach’s Alpha not calculated because scale consists of 1 item 
1 For relatives, standard error of skewness for all scales = 0.1 
2 For controls, Standard error of skewness for all scales = 0.3 
   Relatives Controls 
Mean Group 
Difference 
Scale 
Items, 
n Alpha 
Cases, 
n 
Mean 
(sd) Skewness1 
Cases, 
n 
Mean 
(sd) Skewness2 F p-value 
Social Isolation 10 0.8 478 
1.50 
(0.98) 1.7 88 
1.01 
(0.62) 2.1 20.7 <.001 
Introversion 17 0.9 480 
1.53 
(1.30) 0.7 88 
1.32 
(1.22) 0.7 2.0 .153 
Sexual Anhedonia 4 0.8 365 
1.02 
(1.31) 2.1 53 
0.95 
(1.11) 2.2 0.1 .709 
Social/Interpersonal 
Functioning 1 n/a 443 
0.69 
(0.89) 1.2 88 
0.31 
(0.55) 2.1 14.9 <.001 
Sensitivity 8 0.9 479 
2.08 
(1.38) 0.4 88 
1.85 
(1.24) 0.3 2.1 .147 
Social Anxiety 7 0.8 479 
1.27 
(0.98) 1.1 88 
0.92 
(0.82) 1.2 10.1 .002 
Restricted Emotion 9 0.7 479 
1.44 
(0.75) 0.7 88 
1.32 
(0.66) 0.8 2.0 .158 
Affect 5 0.8 447 
0.34 
(0.46) 1.6 87 
0.18 
(0.30) 1.9 10.1 .002 
Rapport 4 0.9 446 
0.35 
(0.62) 2.2 87 
0.19 
(0.42) 3.0 5.0 .026 
Anger to Perceived 
Slights 
8 
 0.8 479 
1.16 
(1.35) 1.2 88 
0.69 
(1.05) 1.7 9.6 .002 
Suspiciousness 20 0.9 479 
1.07 
(0.95) 1.4 88 
0.69 
(0.76) 1.5 12.1 .001 
Guardedness 3 0.9 447 
0.17 
(0.46) 3.2 88 
0.04 
(0.17) 4.2 7.1 .008 
Irritability 1 n/a 447 
0.11 
(0.38) 3.5 88 
0.13 
(0.42) 3.5 0.1 .810 
Pathological Jealousy 6 0.8 479 
0.79 
(1.26) 1.7 88 
0.35 
(0.78) 2.6 10.0 .002 
Ideas of Reference: 
Being Watched 10 0.9 478 
0.69 
(1.15) 2.0 88 
0.42 
(0.84) 2.5 4.5 .035 
Ideas of Reference: 
Remarks 10 0.9 479 
0.61 
(0.98) 1.8 88 
0.33 
(0.64) 1.9 6.8 .009 
Magical Thinking 23 0.9 479 
0.45 
(0.67) 2.6 88 
0.38 
(0.42) 1.0 0.9 .335 
Psychotic-like 
Phenomena 10 0.7 478 
0.55 
(0.51) 1.7 88 
0.43 
(0.45) 2.0 3.9 .049 
Illusions 8 0.8 478 
0.66 
(0.76) 2.1 88 
0.53 
(0.62) 1.8 2.4 .120 
Organization of 
Speech/ Thought 6 0.8 447 
0.20 
(0.43) 2.5 88 
0.06 
(0.22) 5.3 8.2 .004 
Odd/ Eccentric 
Behavior 4 0.8 447 
0.12 
(0.33) 3.7 88 
0.03 
(0.14) 4.3 5.8 .016 
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Table 13. Heritability of Demographic & Diagnostic Covariates in the Combined Pedigree & Control Sample 
 
 
Note: Covariates = age and sex (age corrected for sex, sex corrected for age) 
* Dichotomized variables:  Sex: male = 0, female = 1; MDD and Substance Dependence: diagnosis absent = 0, present = 1 
 
 
 
 
 
 
 
 
 
 
 Heritability  
Demographic and Diagnostic Covariates h2 p-value 
Age 0.271     <.001 
Sex* 0.078 .257 
Education 0.607 <.001 
MDD* 0.442  .001 
Substance Dependence* 0.403 .002 
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Table 14. Genetic Correlation of Demographic and Diagnostic Variables with Schizophrenia in the 
Combined Pedigree and Control Sample 
 
 
Note: Covariates = age and sex (age corrected for sex, sex corrected for age) 
* Dichotomized variables:  Sex: male = 0, female = 1; MDD, Substance Dependence: diagnosis absent = 0, diagnosis present = 1 
 
 
 
 
 
 
 
 
 
 
 
 
 Genetic Correlation with Schizophrenia 
Demographic and Diagnostic Variables Rg p-value 
Age 0.293 .037 
Sex* -0.129 .681 
Education -0.259  .012 
MDD* -0.503  .002 
Substance Dependence* 0.116  .455 
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 Table 15. Correlations between Covariates and SIS Scales in the Combined Relative and Control Sample 
 
 
Note: Values in table are R (p); Bold: p < .05 
* Dichotomized variables: Sex: male = 0, female = 1; Diagnosis/symptoms: absent = 0, present = 1 
Scale Age Sex* Education MDD*  
Substance 
Dependence* Cluster A*  
 
Social Isolation -0.042 (.315) -0.154 (<.001) -0.237 (<.001) 0.075 (.074) 0.227 (<.001) 0.346 (<.001) 
 
Introversion 0.041 (.325) -0.127 (.002) 0.007 (.870) 0.116 (.006) 0.063 (.133) 0.200 (<.001) 
 
Sexual Anhedonia -0.034 (.419) 0.061 (.149) -0.092 (.029) -0.087 (.039) -0.124 (.003) 0.040 (.341) 
 
Social/Interpersonal 
Functioning -0.093 (.026) -0.115 (.006) -0.245 (<.001) 0.138 (.001) 0.255 (<.001) 0.402 (<.001) 
 
Sensitivity -0.072 (.087) 0.171 (<.001) -0.008 (.847) 0.219 (<.001) 0.118 (.005) 0.176 (<.001) 
 
Social Anxiety -0.187 (<.001) 0.042 (.318) -0.071 (.092) 0.187 (<.001) 0.187 (<.001) 0.285 (<.001) 
 
Restricted Emotion -0.158 (<.001) -0.278 (<.001) -0.215 (<.001) -0.115 (.006) 0.043 (.311) 0.086 (.041) 
 
Affect -0.157 (<.001) -0.138 (.001) -0.238 (<.001) 0.015 (.722) 0.147 (<.001) 0.328 (<.001) 
 
Rapport -0.132 (.002) -0.068 (.108) -0.205 (<.001) -0.008 (.842) 0.060 (.156) 0.270 (<.001) 
 
Anger to Perceived  
Slights -0.201 (<.001) -0.058 (.169) -0.119 (.005) 0.085 (.042) 0.250 (<.001) 0.157 (<.001) 
 
Suspiciousness* -0.121 (.004) -0.044 (.300) -0.078 (.065) 0.046 (.279) 0.080 (.057) 0.058 (.170) 
Guardedness -0.031 (.461) -0.015 (.724) -0.043 (.312) 0.026 (.542) 0.120 (.004) 0.357 (<.001) 
 
Irritability -0.060 (.155) -0.023 (.588) -0.070 (.098) 0.010 (.809) 0.103 (.014) 0.170 (<.001) 
 
Pathological Jealousy -0.183 (<.001) 0.026 (.539) -0.100 (.017) 0.160 (<.001) 0.230 (<.001) 0.147 (<.001) 
 
Ideas of Reference: 
Being Watched* -0.138 (.001) 0.012 (.783) -0.080 (.058) 0.104 (.013) 0.098 (.020) 0.134 (.001) 
 
Ideas of Reference: 
Remarks* -0.190 (<.001) -0.107 (.011) -0.106 (.011) 0.081 (.055) 0.068 (.109) 0.207 (<.001) 
Magical Thinking* 0.004 (.922) 0.044 (.292) 0.012 (.781) 0.044 (.302) 0.116 (.006) 0.093 (.028) 
 
Psychotic-like 
Phenomena 0.001 (.999) -0.042 (.321) -0.049 (.242) 0.189 (<.001) 0.181 (<.001) 0.237 (<.001) 
Illusions* -0.135 (.001) -0.011 (.796) 0.078 (.065) 0.067 (.112) 0.075 (.073) 0.095 (.023) 
 
Organization of 
Speech/ Thought -0.052 (.216) -0.076 (.072) -0.182 (<.001) 0.040 (.341) 0.115 (.006) 0.279 (<.001) 
Odd/ Eccentric 
Behavior* 0.006 (.879) -0.082 (.051) -0.117 (.005) -0.032 (.452) 0.129 (.002) 0.194 (<.001) 
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Table 16. Heritability of SIS Scales in Combined Pedigree and Control Sample 
 
 
* Dichotomized variables: Sex: male = 0, female = 1; Diagnosis/symptoms: absent = 0, present = 1 
 
 
 
 
Heritability 
Cov: age, sex* 
  
Cov: age, sex*, education,  
MDD*, substance dependence* 
Scale h2 p-value  h2 p-value  
Social Isolation 0.392 <.001  0.303 <.001  
Introversion 0.393 <.001  0.404 <.001  
Sexual Anhedonia 0.181   .006  0.191   .006  
Social/Interpersonal Functioning 0.320 <.001  0.254    .001  
Sensitivity 0.442 <.001  0.458 <.001  
Social Anxiety 0.450 <.001  0.431 <.001  
Restricted Emotion 0.401 <.001  0.312 <.001  
Affect 0.361 <.001  0.305 <.001  
Rapport* 0.404 <.001  0.395    .001  
Anger to Perceived Slights 0.323 <.001  0.237   .002  
Suspiciousness* 0.742   .010  0.728    .008  
Guardedness*  0.660 <.001  0.679 <.001  
Irritability* 0.707 <.001  0.757  <.001  
Pathological Jealousy* 0.522 <.001  0.437  <.001  
Ideas of Reference: Being Watched* 0.571 <.001  0.568  <.001  
Ideas of Reference: Remarks* 0.521 <.001  0.511  <.001  
Magical Thinking* 0.675 <.001  0.685 <.001  
Psychotic-like Phenomena 0.306 <.001  0.290  <.001  
Illusions* 0.718 <.001  0.731  <.001  
Org Speech/Thought* 0.406 <.001  0.414  <.001  
Odd/Eccentric Behavior* 0.460 <.001  0.412  <.001  
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Table 17. Genetic Correlations of SIS Scales & Schizophrenia in the Combined Pedigree & Control Sample 
 
 
Note: All scales were significantly different from 1 (or -1)  
* Dichotomized variable: Sex: male = 0, female = 1; Diagnosis/symptoms: absent = 0, present = 1
 
 
Genetic Correlation with Schizophrenia 
 
Cov = Age, sex* 
 
Cov = Age, sex*, education,  
MDD*, substance dependence* 
Scale Rg p-value Rg p-value 
Social Isolation 0.247 .140 0.175 .376 
Introversion 0.029 .884 0.066 .731 
Sexual Anhedonia 0.184 .334 0.176 .340 
Social/Interpersonal Functioning 0.212 .238 0.151 .525 
Sensitivity -0.034 .848 0.055 .785 
Social Anxiety* -0.111 .614 -0.088 .696 
Restricted Emotion -0.041 .822 -0.216 .300 
Affect 0.217 .260 0.154 .479 
Rapport 0.016 .948 -0.114 .653 
Anger to Perceived Slights* 0.178 .510 -0.162 .551 
Suspiciousness* 0.177 .438 0.145 .552 
Guardedness 0.470 .043 0.536 .026 
Irritability* 0.209 .375 0.214 .350 
Pathological Jealousy 0.161 .364 0.146 .470 
Ideas of Reference: Watched* -0.350 .099 -0.391 .052 
Ideas of Reference: Remarks* -0.199 .364 -0.205 .354 
Magical Thinking* -0.304 .099 -0.266 .158 
Psychotic-like Phenomena 0.035 .907 0.131 .562 
Illusions* -0.226 .211 -0.172 .344 
Organization of Speech/Thought 0.259 .210 0.206 .377 
Odd/Eccentric Behavior* -0.035 .898 -0.275 .318 
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Table 18. Correlations among SIS Scales in the Pedigree Sample 
 
 
Note: Cov = age, sex; Values in table are R (p); Bold: p < .05; * Dichotomized scale: symptoms absent = 0, present = 1
SIS Scale 
Social 
Isol. Introv. 
Sexual 
Anhed. 
Social/ 
Interp. Sensit. 
Social 
Anxiety 
Restrict 
Emot. Affect Rapport 
Anger 
Slights Suspic.* Guard. Irritab. 
Pathol. 
Jealous Watch* Remar* 
Magic 
Think.* 
Psychot 
Phen.* Illus.* 
Speech/ 
Thou. 
Odd/ 
Eccent.* 
Social 
Isolation                      
Introversion 
0.434 
(<.001)                     
Sexual 
Anhedonia 
0.111 
(.015) 
0.206 
(<.001)                    
Social/Interp. 
Functioning 
0.567 
(<.001) 
0.435 
(<.001) 
0.045 
(.327)                   
Sensitivity 
0.210 
(<.001) 
0.373 
(<.001) 
0.001 
(.975) 
0.322 
(<.001)                  
Social 
Anxiety 
0.333 
(<.001) 
0.522 
(<.001) 
0.012 
(.799) 
0.397 
(<.001) 
0.631 
(<.001)                 
Restricted 
Emotion 
0.282 
(<.001) 
0.261 
(<.001) 
0.163 
(<.001) 
0.265 
(<.001) 
-0.006 
(.904) 
0.121 
(.008)                
Affect 
0.367 
(<.001) 
0.259 
(.001) 
-0.003 
(.954) 
0.628 
(<.001) 
0.193 
(<.001) 
0.243 
(<.001) 
0.287 
(<.001)               
Rapport 
0.321 
(<.001) 
0.238 
(<.001) 
0.009 
(.837) 
0.546 
(<.001) 
0.174 
(<.001) 
0.194 
(<.001) 
0.238 
(<.001) 
0.793 
(<.001)              
Anger to 
Perc. Slights 
0.256 
(<.001) 
0.215 
(<.001) 
-0.033 
(.474) 
0.337 
(<.001) 
0.469 
(<.001) 
0.359 
(<.001) 
0.034 
(.464) 
0.244 
(<.001) 
0.185 
(<.001)             
Suspicious.* 
0.120 
(.009) 
0.183 
(<.001) 
0.023 
(.616) 
0.131 
(.004) 
0.242 
(<.001) 
0.168 
(<.001) 
0.046 
(.314) 
0.103 
(.025) 
0.097 
(.034) 
0.148 
(.001)            
Guarded. 
0.226 
(<.001) 
0.111 
(.016) 
-0.081 
(.077) 
0.292 
(<.001) 
0.211 
(<.001) 
0.169 
(<.001) 
0.008 
(.861) 
0.416 
(<.001) 
0.379 
(<.001) 
0.207 
(<.001) 
0.045 
(.329)           
Irritability 
0.214 
(<.001) 
0.123 
(.007) 
-0.024 
(.604) 
0.362 
(<.001) 
0.113 
(.013) 
0.162 
(<.001) 
0.140 
(.002) 
0.496 
(<.001) 
0.408 
(<.001) 
0.273 
(<.001) 
0.045 
(.323) 
0.422 
(<.001)          
Pathological 
Jealousy 
0.234 
(<.001) 
0.235 
(<.001) 
-0.134 
(.003) 
0.379 
(<.001) 
0.409 
(<.001) 
0.428 
(<.001) 
0.085 
(.064) 
0.199 
(<.001) 
0.123 
(.007) 
0.427 
(<.001) 
0.089 
(.052) 
0.114 
(.012) 
0.176 
(<.001)         
Ideas of Ref. 
Watched* 
0.176 
(<.001) 
0.176 
(<.001) 
0.018 
(.697) 
0.197 
(<.001) 
0.308 
(<.001) 
0.399 
(<.001) 
0.050 
(.274) 
0.123 
(.007) 
0.160 
(<.001) 
0.303 
(<.001) 
0.175 
(<.001) 
0.161 
(<.001) 
0.090 
(.050) 
0.231 
(<.001)        
Ideas of Ref. 
Remarks* 
0.135 
(.003) 
0.151 
(.001) 
-0.078 
(.089) 
0.230 
(<.001) 
0.316 
(<.001) 
0.394 
(<.001) 
0.004 
(.926) 
0.119 
(.009) 
0.128 
(.005) 
0.314 
(<.001) 
0.124 
(.006) 
0.107 
(.019) 
0.116 
(.011) 
0.291 
(<.001) 
0.302 
(<.001)       
Magical 
Thinking* 
0.106 
(.021) 
0.104 
(.023) 
0.074 
(.106) 
0.133 
(.003) 
0.239 
(<.001) 
0.175 
(<.001) 
-0.043 
(.351) 
0.031 
(.495) 
0.101 
(.027) 
0.245 
(<.001) 
0.155 
(.001) 
0.117 
(.011) 
0.115 
(.012) 
0.175 
(<.001) 
0.335 
(<.001) 
0.203 
(<.001)      
Psychotic. 
Phenomena* 
0.091 
(.046) 
0.246 
(<.001) 
0.103 
(.024) 
0.015 
(.001) 
0.368 
(<.001) 
0.297 
(<.001) 
-0.004 
(.935) 
0.071 
(.124) 
0.086 
(.061) 
0.306 
(<.001) 
0.157 
(.001) 
0.127 
(.005) 
0.078 
(.089) 
0.229 
(<.001) 
0.251 
(<.001) 
0.278 
(<.001) 
0.350 
(<.001)     
Illusions* 
-0.003 
(.949) 
0.120 
(.009) 
0.038 
(.408) 
0.056 
(.223) 
0.282 
(<.001) 
0.234 
(<.001) 
-0.094 
(.040) 
-0.067 
(.142) 
-0.002 
(.957) 
0.213 
(<.001) 
0.095 
(.038) 
0.060 
(.191) 
0.025 
(.583) 
0.167 
(<.001) 
0.195 
(<.001) 
0.293 
(<.001) 
0.333 
(<.001) 
0.408 
(<.001)    
Org. Speech/ 
Thought 
0.301 
(<.001) 
0.163 
(<.001) 
0.053 
(.249) 
0.532 
(<.001) 
0.279 
(<.001) 
0.226 
(<.001) 
0.048 
(.293) 
0.519 
(<.001) 
0.524 
(<.001) 
0.240 
(<.001) 
0.081 
(.075) 
0.309 
(.001) 
0.274 
(<.001) 
0.233 
(<.001) 
0.143 
(.002) 
0.136 
(.003) 
0.161 
(<.001) 
0.135 
(.003) 
0.047 
(.304)   
Odd/Eccent. 
Behavior* 
0.251 
(<.001) 
0.167 
(<.001) 
-0.043 
(.349) 
0.410 
(<.001) 
0.169 
(<.001) 
0.189 
(<.001) 
0.163 
(<.001) 
0.472 
(<.001) 
0.416 
(<.001) 
0.216 
(<.001) 
0.073 
(.111) 
0.296 
(<.001) 
0.333 
(<.001) 
0.226 
(<.001) 
0.157 
(.001) 
0.124 
(.007) 
0.086 
(.061) 
0.124 
(.006) 
-
0.007 
(.874) 
0.381 
(<.001)  
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Table 19. Correlation of SIS Scales and SIS Phenotypic Factors 
 
 
Note: Cov = age, sex; Bold: R > .300 
*Dichotomized scale: symptoms absent = 0, present = 1 
 
 
 
Genetic Correlation 
Scale I. Observed Behavior 
II. Cognitive-
Perceptual 
III. Social-
Interpersonal IV. Paranoid 
Affect 0.869 -0.054 0.210 0.094 
Rapport 0.792 0.056 0.196 0.010 
Social/Interpersonal Functioning 0.615 0.030 0.376 0.365 
Organization of Speech/Thought 0.585 0.126 0.101 0.150 
Irritability 0.559 0.061 -0.002 0.097 
Odd/Eccentric Behavior* 0.535 0.037 0.065 0.160 
Guardedness 0.511 0.126 -0.063 0.110 
Psychotic-like Phenomena* 0.055 0.600 0.089 0.206 
Magical Thinking* 0.101 0.573 0.005 0.086 
Illusions* -0.054 0.569 -0.040 0.163 
Ideas of Reference: Watched* 0.128 0.368 0.058 0.312 
Introversion 0.112 0.135 0.632 0.371 
Social Isolation 0.346 0.002 0.454 0.281 
Sexual Anhedonia -0.066 0.168 0.426 -0.196 
Restricted Emotions 0.189 -0.116 0.415 0.030 
Social Anxiety 0.119 0.238 0.280 0.701 
Sensitivity 0.133 0.361 0.102 0.614 
Pathological Jealousy 0.189 0.130 -0.007 0.586 
Anger to Perceived Slights 0.258 0.303 -0.017 0.478 
Ideas of Reference: Remarks 0.111 0.319 -0.040 0.401 
Suspiciousness* 0.061 0.199 0.123 0.153 
     Factor Eigenvalue 5.529 2.544 1.543 1.238 
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Table 20. Genetic Correlations among SIS Scales in the Pedigree Sample 
 
Note: Cov = age, sex; Values in table are Rg (p); Bold: p < .05; * Dichotomized scale: symptoms absent = 0, present = 1 
Scale 
Social 
Isol. Introv. 
Sexual 
Anhed. 
Social/ 
Interp. Sensit. 
Social 
Anxiety 
Restrict 
Emot. Affect Rapport 
Anger 
Slights Suspic.* Guard. Irritab. 
Pathol. 
Jealous Watch* Remark* 
Magic 
Think.* 
Psychot 
Phen.* Illus.* 
Speech/ 
Thou. 
Odd/ 
Eccen.* 
Social 
Isolation                      
Introversion 
0.519 
(.012)                     
Sexual 
Anhedonia 
-0.242 
(.365) 
0.457 
(.081)                    
Social/Interp. 
Functioning 
0.725 
(.001) 
0.657 
(.001) 
0.038 
(.887)                   
Sensitivity 
0.198 
(.295) 
0.645 
(<.001) 
0.050 
(.832) 
0.233 
(.247)                  
Social 
Anxiety 
0.385 
(.049) 
0.838 
(<.001) 
0.013 
(.962) 
0.571 
(.005) 
0.848 
(<.001)                 
Restricted 
Emotion 
0.561 
(.002) 
0.534 
(.004) 
0.298 
(.288) 
0.667 
(.001) 
-0.306 
(.085) 
0.214 
(.250)                
Affect 
0.610 
(.005) 
0.454 
(.029) 
-0.042 
(.874) 
0.865 
(<.001) 
-0.149 
(.462) 
0.260 
(.191) 
0.819 
(<.001)               
Rapport 
0.621 
(.017) 
0.263 
(.291) 
0.005 
(.987) 
0.886 
(.001) 
-0.073 
(.756) 
0.186 
(.422) 
0.719 
(.002) 
0.950 
(<.001)              
Anger to 
Perc. Slights 
0.562 
(.012) 
0.472 
(.022) 
0.292 
(.274) 
0.631 
(.005) 
0.624 
(.001) 
0.706 
(.001) 
0.308 
(.121) 
0.245 
(.312) 
0.177 
(.535)             
Suspicious.* 
0.479 
(.132) 
0.339 
(.264) 
-0.093 
(.758) 
0.489 
(.129) 
0.515 
(.048) 
0.493 
(.091) 
-0.362 
(.225) 
0.397 
(.209) 
0.538 
(.134) 
0.480 
(.133)            
Guarded. 
0.301 
(.198) 
0.168 
(.471) 
0.157 
(.656) 
0.438 
(.069) 
0.215 
(.327) 
0.062 
(.757) 
0.330 
(.132) 
0.305 
(.143) 
0.454 
(.001) 
0.256 
(.370) 
0.185 
(.679)           
Irritability 
0.421 
(.213) 
0.305 
(.355) 
0.039 
(.913) 
0.367 
(.378) 
-0.009 
(.978) 
0.165 
(.569) 
0.522 
(.067) 
0.286 
(.398) 
0.560 
(.088) 
-0.034 
(.937) 
0.309 
(.482) 
0.675 
(.001)          
Pathological 
Jealousy 
0.767 
(<.001) 
0.703 
(.001) 
0.107 
(.690) 
0.743 
(<.001) 
0.713 
(<.001) 
0.873 
(<.001) 
0.025 
(.903) 
0.242 
(.252) 
0.187 
(.446) 
0.818 
(<.001) 
0.958 
(.003) 
0.309 
(.185) 
0.427 
(.229)         
Ideas of Ref. 
Watched* 
0.481 
(.021) 
0.460 
(.020) 
-0.106 
(.657) 
0.720 
(<.001) 
0.716 
(<.001) 
0.675 
(<.001) 
0.096 
(.614) 
0.536 
(.008) 
0.682 
(.001) 
0.836 
(.001) 
0.818 
(.006) 
0.446 
(.136) 
0.425 
(.117) 
0.928 
(<.001)        
Ideas of Ref. 
Remarks* 
0.238 
(.254) 
0.410 
(.051) 
-0.194 
(.415) 
0.497 
(.013) 
0.673 
(<.001) 
0.839 
(<.001) 
-0.046 
(.814) 
0.066 
(.750) 
0.143 
(.519) 
0.638 
(.003) 
0.517 
(.099) 
0.118 
(.695) 
-0.006 
(.982) 
0.806 
(<.001) 
0.877 
(<.001)       
Magical 
Thinking* 
0.223 
(.271) 
0.259 
(.190) 
0.204 
(.356) 
0.335 
(.088) 
0.753 
(<.001) 
0.406 
(.033) 
-0.188 
(.294) 
0.135 
(.481) 
0.399 
(.056) 
0.749 
(<.001) 
0.608 
(.016)  
0.343 
(.209) 
0.191 
(.422) 
0.572 
(.006) 
0.685 
(<.001) 
0.367 
(.071)      
Psychotic. 
Phenomena* 
0.314 
(.050) 
0.687 
(<.001) 
0.466 
(.053) 
0.279 
(.126) 
0.996 
(<.001) 
0.918 
(<.001) 
-0.120 
(.479) 
0.066 
(.710) 
0.283 
(.144) 
0.607 
(.001) 
0.550 
(.003) 
0.339 
(.200) 
0.105 
(.637) 
0.742 
(<.001) 
0.486 
(.004) 
0.761 
(<.001) 
0.597 
(<.001)     
Illusions* 
-0.222 
(.260) 
0.075 
(.688) 
0.583 
(.024) 
-0.033 
(.866) 
0.835 
(<.001) 
0.506 
(.005) 
-0.315 
(.073) 
-0.374 
(.052) 
-0.165 
(.424) 
0.267 
(.166) 
0.320 
(.228) 
0.344 
(.190) 
0.013 
(.956) 
0.407 
(.031) 
0.136 
(.479) 
0.612 
(.001) 
0.818 
(<.001) 
0.923 
(<.001)    
Org. Speech/ 
Thought 
0.614 
(.014) 
0.485 
(.041) 
0.573 
(.064) 
0.963 
(<.001) 
0.313 
(0.133) 
0.520 
(.020) 
0.540 
(.035) 
0.820 
(.002) 
0.931 
(<.001) 
0.095 
(.736) 
0.653 
(.088) 
0.766 
(.002) 
0.685 
(.036) 
0.653 
(.003) 
0.445 
(.059) 
0.171 
(.461) 
0.383 
(.077) 
0.467 
(.027) 
0.197 
(.343)   
Odd/Eccent. 
Behavior* 
0.082 
(.721) 
0.727 
(.001) 
-0.022 
(.937) 
0.589 
(.008) 
0.177 
(.411) 
0.531 
(.018) 
0.440 
(.041)  
0.330 
(.157) 
0.463 
(.055) 
0.278 
(.241) 
0.413 
(.220) 
0.063 
(.857)  
0.446 
(.117) 
0.407 
(.079) 
0.733 
(.001) 
0.661 
(.008) 
0.437 
(.074) 
0.215 
(.284) 
0.207 
(.342) 
0.357 
(.162)  
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Table 21. Correlations of SIS Scales and SIS Genetic Factors 
 
 
Note: Cov = age, sex; Bold: R > .400 
* Dichotomized scale: symptoms absent = 0, present = 1 
 
 
 
Correlation 
 
Scale 
 
I. 
Paranoid 
Fears 
II. 
Interpersonal 
Deficits 
III. Perceptual 
Distortions 
IV. Constricted 
Affect 
V. Eccentric 
Behavior 
VI. Unusual 
Beliefs 
Social Anxiety 0.943 0.097 -0.081 0.216 -0.225 0.079 
Pathological Jealousy 0.914 0.380 0.090 -0.005 0.035 0.270 
Sensitivity 0.871 -0.028 -0.278 -0.248 -0.031 0.273 
Psychotic-like Phenomena* 0.856 0.153 -0.493 -0.110 0.011 0.153 
Ideas of Reference: 
Remarks* 0.761 -0.005 0.094 -0.069 -0.439 0.299 
Introversion 0.716 0.222 -0.206 0.563 -0.236 -0.104 
Suspiciousness* 0.601 0.533 0.225 -0.382 -0.051 0.248 
Ideas of Reference: 
Watched* 0.580 0.458 0.246 -0.039 -0.385 0.576 
Organization of 
Speech/Thought 0.303 1.002 -0.282 0.133 0.030 -0.074 
Rapport -0.030 0.933 0.099 0.217 -0.204 0.232 
Affect 0.028 0.733 0.214 0.492 -0.075 0.149 
Social/Interpersonal 
Functioning 0.381 0.702 0.125 0.454 -0.164 0.277 
Irritability 0.070 0.673 -0.045 0.043 -0.167 -0.103 
Guardedness 0.074 0.617 -0.272 -0.055 0.043 0.150 
Social Isolation 0.423 0.553 0.335 0.384 0.324 0.206 
Sexual Anhedonia 0.039 0.112 -0.873 0.211 0.095 0.004 
Illusions* 0.474 -0.037 -0.757 -0.476 -0.160 0.214 
Restricted Emotion -0.139 0.474 -0.121 0.908 -0.168 0.019 
Odd/Eccentric Behavior* 0.317 0.280 0.031 0.193 -0.918 0.086 
Anger to Perceived Slights 0.572 0.025 -0.076 0.321 0.041 0.827 
Magical Thinking* 0.362 0.288 -0.330 -0.322 -0.179 0.680 
       Factor Eigenvalue 9.700 4.477 2.208 1.768 1.272 1.046 
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Table 22. Beta Weights for Deriving Genetic Factor Scores 
 
Scale 
I. Paranoid 
Fears 
II. Interpersonal 
Deficits 
III. Perceptual 
Distortions 
IV. Constricted 
Affect 
V. Eccentric 
Behavior 
VI. Unusual 
Beliefs 
Social Anxiety 0.201 -0.119 -0.163 0.023 0.217 0.021 
Pathological Jealousy 0.236 -0.109 0.137 0.105 0.129 -0.0431 
Sensitivity 0.206 0.046 0.074 0.018 0.102 0.012 
Psychoticlike 
Phenomena* 0.088 0.117 -0.194 -0.167 0.070 -0.129 
Ideas of Reference: 
Remarks* 0.150 -0.100 0.141 0.055 -0.366 -0.046 
Introversion 0.229 -0.077 -0.031 0.204 -0.233 -0.414 
Suspiciousness* 0.170 0.046 0.159 -0.336 0.031 -0.180 
Ideas of Reference: 
Watched* -0.016 0.007 0.232 0.088 -0.066 0.407 
Organization of 
Speech/Thought 0.031 0.291 -0.094 -0.076 0.198 -0.109 
Rapport -0.334 0.569 -0.077 -0.315 0.061 0.306 
Affect 0.217 -0.378 0.156 0.508 -0.247 -0.256 
Social/Interpersonal 
Functioning -0.145 0.544 0.028 -0.166 -0.009 0.014 
Irritability  -0.012 0.239 0.013 -0.084 -0.100 -0.145 
Guardedness -0.020 -0.011 -0.147 -0.112 0.010 -0.063 
Social Isolation 0.118 0.051 0.139 0.210 0.356 0.0298 
Sexual Anhedonia -0.082 0.077 -0.380 0.174 0.121 0.136 
Illusions* 0.104 -0.159 -0.243 -0.008 -0.183 -0.128 
Restricted Emotion -0.007 -0.202 -0.075 0.468 -0.064 0.109 
Odd/Eccentric 
Behavior* -0.051 -0.05957 -0.042 0.006 -0.594 -0.098 
Anger to Perceived 
Slights -0.063 -0.11606 -0.055 0.098 0.194 0.559 
Magical Thinking* -0.146 -0.0151 -0.206 -0.102 -0.139 0.433 
 
* Dichotomized scales: symptoms absent = 0, present = 1 
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Table 23. Genetic Correlations among the SIS Genetic Factors in the Combined Pedigree & Control Sample 
 
Factor Paranoid Fears 
Interpersonal 
Deficits 
Perceptual 
Distortions1 
Constricted 
Affect 
Eccentric 
Behavior1 
Unusual 
Beliefs 
I. Paranoid Fears 
      
II. Interpersonal Deficits 0.004 (.985) 
     
III. Perceptual Distortions1 0.182 (.193) -0.126 (.498) 
    
IV. Constricted Affect -0.055 (.733) 0.194 (.403) -0.256 (.065) 
   
V. Eccentric Behavior1 -0.032 (.839) -0.212 (.319) -0.027 (.855) -0.054 (.752) 
  
VI. Unusual Beliefs -0.151 (.361) -0.017 (.939) 0.050 (.745) 0.064 (.717) -0.085 (.641) 
  
Note: Cov = age, sex; Values in table are Rg (p) 
1Direction of scale is reversed 
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Table 24. Heritability of SIS Genetic Factor Scores in the Combined Pedigree and Control Sample 
 
 
* Dichotomized variables: Sex:  male = 0, female = 1; Diagnosis: absent = 0, present = 1  
 
 
 
 
 
 
 
 
 
 Heritability  
 Cov: age, sex* 
 
Cov: age, sex*, education,  
MDD*, substance dependence* 
Factor h2 p-value h2 p-value 
I. Paranoid Fears 0.560 <.001 0.565 <.001 
II. Interpersonal Deficits 0.246 <.001 0.245 <.001 
III. Perceptual Distortions 0.576 <.001 0.564 <.001 
IV. Constricted Affect 0.500 <.001 0.436 <.001 
V. Eccentric Behavior 0.396 <.001 0.389 <.001 
VI. Unusual Beliefs 0.400 <.001 0.381 <.001 
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Table 25. Genetic Correlations of SIS Genetic Factor Scores and Schizophrenia in the Combined Pedigree 
and Control Sample 
 
Note: all scales were significantly different from 1 (or -1); Bold: p < .05  
* Dichotomized variable: Sex: male = 0, female = 1; Diagnosis absent = 0, present = 1  
1Direction of scale is reversed 
 
 
 
 
 
 
 
 
 
 
 
Genetic Correlation with Schizophrenia 
 
Cov = Age, sex* 
 
Cov = Age, sex*, education,  
MDD*, substance dependence* 
Factor Rg p-value Rg p-value 
I. Paranoid Fears 0.076 .630 0.085 .615 
II. Interpersonal Deficits 0.270 .194 0.198 .380 
III. Perceptual Distortions1 -0.038 .789 0.024 .862 
IV. Constricted Affect 0.040 .815 -0.047 .794 
V. Eccentric Behavior1 -0.522 .046 -0.445 .048 
VI. Unusual Beliefs -0.446 .022 -0.468 .015 
110 
Table 26. Genetic Correlations of SIS Genetic Factor Scores and MDD in the Combined Pedigree and 
Control Sample 
 
Note: all scales were significantly different from 1 (or -1)  
* Dichotomized variable: Sex: male = 0, female = 1; Diagnosis absent = 0, present = 1 
1Direction of scale is reversed 
 
 
 
 
 
 
 
 
 
 
 
 
Genetic Correlation with MDD 
 
Cov = Age, sex* 
 
Cov = Age, sex*, education,  
substance dependence* 
Factor Rg p-value Rg p-value 
I. Paranoid Fears 0.194 .313 0.169 .379 
II. Interpersonal Deficits -0.249 .371 -0.282 .336 
III. Perceptual Distortions1 -0.219 .286 -0.306 .151 
IV. Constricted Affect -0.273 .206 -0.270 .250 
V. Eccentric Behavior1 -0.073 .746 -0.065 .769 
VI. Unusual Beliefs  0.170 .466 0.172 .457 
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Table 27. Genetic Correlations of SIS Genetic Factor Scores and Substance Dependence in the Combined 
Pedigree and Control Sample 
 
 
Note: all scales were significantly different from 1 (or -1)  
* Dichotomized variable: Sex: male = 0, female = 1; Diagnosis absent = 0, present = 1 
1Direction of scale is reversed 
 
 
Genetic Correlation with Substance Dependence 
 
Cov = Age, sex* 
 
Cov = Age, sex*, education, 
MDD* 
Factor Rg p-value Rg p-value 
I. Paranoid Fears 0.359 .082 0.421 .088 
II. Interpersonal Deficits 0.390 .153 0.290 .381 
III. Perceptual Distortions1 -0.232 .237 -0.156 .493 
IV. Constricted Affect 0.415 .109 0.365 .268 
V. Eccentric Behavior1 -0.344 .121 -0.362 .165 
VI. Unusual Beliefs 0.268 .265 0.210 .464 
